| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 417,419 | Sold Some | -150 | -0.03 % | $4,925,544 | $4,925,544 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of King Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | 1,515,302 | Sold Some | -3,505,062 | -69.81 % | $17,880,564 | $17,880,564 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -303,041 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Rs Variable Products Trust - Rs Partners Vip Series | Specialty & Misc | | Sold All | -4,764 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Rs Variable Products Trust - Rs Partners Vip Series Ownership Of King Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR | Ziegler Capital Management Llc | Institution | 23,090 | Sold Some | -1,850 | -7.41 % | $272,462 | $272,462 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ziegler Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR | Advent Capital Management | Institution | 434 | New Holding | 434 | 100 % | $5,104 | $5,121 | $17 | 0.34 % | $17 | | | | | | News Article | History of Advent Capital Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | 967,400 | Sold Some | -1,074,700 | -52.62 % | $10,825,206 | $11,415,320 | $590,114 | 5.45 % | $-655,567 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-18 | 2008-09-30 | 13F-HR/A | Yale Capital Corp | Institution | 15,000 | No Change | 0 | 0 % | $167,850 | $177,000 | $9,150 | 5.45 % | $0 | | | | | | News Article | History of Yale Capital Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 513,159 | Added More | 29,724 | 6.14 % | $5,793,565 | $6,055,276 | $261,711 | 4.51 % | $15,159 | | | | | | News Article | History of Amvescap Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 589,801 | Sold Some | -34,546 | -5.53 % | $6,658,853 | $6,959,652 | $300,799 | 4.51 % | $-17,618 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Integrity Asset Management Llc | Institution | 1,585,370 | Added More | 123,744 | 8.46 % | $17,898,827 | $18,707,366 | $808,539 | 4.51 % | $63,109 | | | | | | News Article | History of Integrity Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Rothschild Asset Management Inc | Institution | 748,596 | Sold Some | -30,773 | -3.94 % | $8,451,649 | $8,833,433 | $381,784 | 4.51 % | $-15,694 | | | | | | News Article | History of Rothschild Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | N-Q | Wegener Investment Trust - Wegener Investment Trust | Specialty & Misc | | Sold All | -1,400 | -100 % | | | | 4.51 % | $-714 | | | | | | News Article | History of Wegener Investment Trust - Wegener Investment Trust Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 855,374 | Sold Some | -568,159 | -39.91 % | $9,657,172 | $10,093,413 | $436,241 | 4.51 % | $-289,761 | | | | | | News Article | History of Wells Fargo And Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-17 | 2008-12-31 | 13F-HR/A | Yale Capital Corp | Institution | 15,000 | No Change | 0 | 0 % | $169,350 | $177,000 | $7,650 | 4.51 % | $0 | | | | | | News Article | History of Yale Capital Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 94,746 | Added More | 1,229 | 1.31 % | $1,084,842 | $1,118,003 | $33,161 | 3.05 % | $430 | | | | | | News Article | History of American International Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 117,025 | Sold Some | -106,033 | -47.53 % | $1,339,936 | $1,380,895 | $40,959 | 3.05 % | $-37,112 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bogle Investment Management L P | Institution | 52,400 | Sold Some | -116,069 | -68.89 % | $599,980 | $618,320 | $18,340 | 3.05 % | $-40,624 | | | | | | News Article | History of Bogle Investment Management L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Catapult Capital Management Llc | Institution | 427,801 | Added More | 227,801 | 113.90 % | $4,898,321 | $5,048,052 | $149,730 | 3.05 % | $79,730 | | | | | | News Article | History of Catapult Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 50,376 | Added More | 21,207 | 72.70 % | $576,805 | $594,437 | $17,632 | 3.05 % | $7,422 | | | | | | News Article | History of Citadel L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cna Financial Corp | Institution | 790 | Added More | 300 | 61.22 % | $9,046 | $9,322 | $277 | 3.05 % | $105 | | | | | | News Article | History of Cna Financial Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Connor Clark And Lunn Investment Management Ltd | Institution | 164,900 | Sold Some | -3,100 | -1.84 % | $1,888,105 | $1,945,820 | $57,715 | 3.05 % | $-1,085 | | | | | | News Article | History of Connor Clark And Lunn Investment Management Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | 200,000 | Sold Some | -1,400,161 | -87.50 % | $2,290,000 | $2,360,000 | $70,000 | 3.05 % | $-490,056 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 842,024 | Added More | 163,169 | 24.03 % | $9,641,175 | $9,935,883 | $294,708 | 3.05 % | $57,109 | | | | | | News Article | History of Eaton Vance Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 842,024 | Added More | 162,647 | 23.94 % | $9,641,175 | $9,935,883 | $294,708 | 3.05 % | $56,926 | | | | | | News Article | History of Eaton Vance Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 60,000 | Sold Some | -449,000 | -88.21 % | $687,000 | $708,000 | $21,000 | 3.05 % | $-157,150 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | 3,949,930 | Added More | 1,130,110 | 40.07 % | $45,226,699 | $46,609,174 | $1,382,476 | 3.05 % | $395,539 | | | | | | News Article | History of Fidelity International Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 335 | Sold Some | -760 | -69.40 % | $3,836 | $3,953 | $117 | 3.05 % | $-266 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Financial Counselors Inc | Institution | 400 | No Change | 0 | 0 % | $4,580 | $4,720 | $140 | 3.05 % | $0 | | | | | | News Article | History of Financial Counselors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 33,267,007 | Added More | 8,385,828 | 33.70 % | $380,907,230 | $392,550,683 | $11,643,452 | 3.05 % | $2,935,040 | | | | | | News Article | History of Fmr Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Fuller And Thaler Asset Management Inc | Institution | | Sold All | -400 | -100 % | | | | 3.05 % | $-140 | | | | | | News Article | History of Fuller And Thaler Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 135,000 | Sold Some | -45,000 | -25.00 % | $1,545,750 | $1,593,000 | $47,250 | 3.05 % | $-15,750 | | | | | | News Article | History of Galleon Management L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 223,107 | Sold Some | -173,024 | -43.67 % | $2,554,575 | $2,632,663 | $78,087 | 3.05 % | $-60,558 | | | | | | News Article | History of Ing Groep Nv Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Julius Baer Investment Management Llc | Institution | 4,610 | Sold Some | -8,780 | -65.57 % | $52,785 | $54,398 | $1,614 | 3.05 % | $-3,073 | | | | | | News Article | History of Julius Baer Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Karsch Capital Management Lp | Institution | 440,920 | New Holding | 440,920 | 100 % | $5,048,534 | $5,202,856 | $154,322 | 3.05 % | $154,322 | | | | | | News Article | History of Karsch Capital Management Lp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Laffer Investments | Institution | 11,000 | No Change | 0 | 0 % | $125,950 | $129,800 | $3,850 | 3.05 % | $0 | | | | | | News Article | History of Laffer Investments Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | | Sold All | -1,061,462 | -100 % | | | | 3.05 % | $-371,512 | | | | | | News Article | History of Leuthold Weeden Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mackenzie Financial Corp | Institution | 25,411 | Added More | 259 | 1.02 % | $290,956 | $299,850 | $8,894 | 3.05 % | $91 | | | | | | News Article | History of Mackenzie Financial Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 1,089,214 | Sold Some | -102,930 | -8.63 % | $12,471,500 | $12,852,725 | $381,225 | 3.05 % | $-36,026 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Street Partners Llc | Institution | 20,000 | New Holding | 20,000 | 100 % | $229,000 | $236,000 | $7,000 | 3.05 % | $7,000 | | | | | | News Article | History of Madison Street Partners Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Magnetar Financial Llc | Institution | | Sold All | -31,079 | -100 % | | | | 3.05 % | $-10,878 | | | | | | News Article | History of Magnetar Financial Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Maverick Capital Ltd | Institution | 6,466,620 | New Holding | 6,466,620 | 100 % | $74,042,799 | $76,306,116 | $2,263,317 | 3.05 % | $2,263,317 | | | | | | News Article | History of Maverick Capital Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 2,582,916 | Sold Some | -379,127 | -12.79 % | $29,574,388 | $30,478,409 | $904,021 | 3.05 % | $-132,694 | | | | | | News Article | History of Millennium Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 1,255,298 | Added More | 417,426 | 49.81 % | $14,373,162 | $14,812,516 | $439,354 | 3.05 % | $146,099 | | | | | | News Article | History of Morgan Stanley Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 847,094 | New Holding | 847,094 | 100 % | $9,699,226 | $9,995,709 | $296,483 | 3.05 % | $296,483 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -174,200 | -100 % | | | | 3.05 % | $-60,970 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 2,575,899 | Added More | 34,448 | 1.35 % | $29,494,044 | $30,395,608 | $901,565 | 3.05 % | $12,057 | | | | | | News Article | History of Northern Trust Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Nyl Trust Co | Institution | 40,572 | Sold Some | -10,285 | -20.22 % | $464,549 | $478,750 | $14,200 | 3.05 % | $-3,600 | | | | | | News Article | History of Nyl Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 595,539 | Sold Some | -628,125 | -51.33 % | $6,818,922 | $7,027,360 | $208,439 | 3.05 % | $-219,844 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 1,854,583 | Sold Some | -2,785,528 | -60.03 % | $21,234,975 | $21,884,079 | $649,104 | 3.05 % | $-974,935 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 67,393 | Added More | 45,728 | 211.06 % | $771,650 | $795,237 | $23,588 | 3.05 % | $16,005 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sigma Capital Management Llc | Institution | 1,000,000 | Sold Some | -50,000 | -4.76 % | $11,450,000 | $11,800,000 | $350,000 | 3.05 % | $-17,500 | | | | | | News Article | History of Sigma Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | State Treasurer State Of Michigan | Institution | 138,711 | Sold Some | -2,600 | -1.83 % | $1,588,241 | $1,636,790 | $48,549 | 3.05 % | $-910 | | | | | | News Article | History of State Treasurer State Of Michigan Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Thales Fund Management Llc | Institution | 41,441 | Added More | 16,639 | 67.08 % | $474,499 | $489,004 | $14,504 | 3.05 % | $5,824 | | | | | | News Article | History of Thales Fund Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 765,580 | Added More | 422,444 | 123.11 % | $8,765,891 | $9,033,844 | $267,953 | 3.05 % | $147,855 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 116,043 | Sold Some | -13,900 | -10.69 % | $1,328,692 | $1,369,307 | $40,615 | 3.05 % | $-4,865 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 10,559 | Sold Some | -36 | -0.33 % | $120,901 | $124,596 | $3,696 | 3.05 % | $-13 | | | | | | News Article | History of Us Bancorp De Ownership Of King Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 18,269,714 | Added More | 3,490,914 | 23.62 % | $209,188,225 | $215,582,625 | $6,394,400 | 3.05 % | $1,221,820 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Co | Institution | | Sold All | -8,526 | -100 % | | | | 5.92 % | $-5,627 | | | | | | News Article | History of Wilmington Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-10-31 | 13F-HR | Peak6 Investments L P | Institution | 53,800 | Sold Some | -12,000 | -18.23 % | $599,332 | $634,840 | $35,508 | 5.92 % | $-7,920 | | | | | | News Article | History of Peak6 Investments L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 2,800,636 | Sold Some | -654,349 | -18.93 % | $31,199,085 | $33,047,505 | $1,848,420 | 5.92 % | $-431,870 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ascend Capital Llc | Institution | 600,000 | Added More | 50,000 | 9.09 % | $6,684,000 | $7,080,000 | $396,000 | 5.92 % | $33,000 | | | | | | News Article | History of Ascend Capital Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 9,921,523 | Sold Some | -293,287 | -2.87 % | $110,525,766 | $117,073,971 | $6,548,205 | 5.92 % | $-193,569 | | | | | | News Article | History of Axa Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Oklahoma National Association | No Data | | Sold All | -18,120 | -100 % | | | | 5.92 % | $-11,959 | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 758,325 | Sold Some | -303,720 | -28.59 % | $8,447,741 | $8,948,235 | $500,495 | 5.92 % | $-200,455 | | | | | | News Article | History of Barclays Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 166,649 | Sold Some | -76,512 | -31.46 % | $1,856,470 | $1,966,458 | $109,988 | 5.92 % | $-50,498 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 136,841 | Added More | 79,295 | 137.79 % | $1,524,409 | $1,614,724 | $90,315 | 5.92 % | $52,335 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Brandywine Asset Management Llc | Institution | 713,060 | Added More | 6,040 | 0.85 % | $7,943,488 | $8,414,108 | $470,620 | 5.92 % | $3,986 | | | | | | News Article | History of Brandywine Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 3,534 | Added More | 911 | 34.73 % | $39,369 | $41,701 | $2,332 | 5.92 % | $601 | | | | | | News Article | History of Capital Fund Management S A Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 141,385 | Added More | 28,681 | 25.44 % | $1,575,029 | $1,668,343 | $93,314 | 5.92 % | $18,929 | | | | | | News Article | History of Caxton Associates Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clifton Group Investment Management Co | No Data | 4,600 | Sold Some | -1,200 | -20.68 % | $51,244 | $54,280 | $3,036 | 5.92 % | $-792 | | | | | | News Article | History of Clifton Group Investment Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 304,471 | Sold Some | -10,807 | -3.42 % | $3,391,807 | $3,592,758 | $200,951 | 5.92 % | $-7,133 | | | | | | News Article | History of Credit Agricole S A Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 516,036 | Added More | 47,787 | 10.20 % | $5,748,641 | $6,089,225 | $340,584 | 5.92 % | $31,539 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dnb Asset Management Us Inc | Institution | | Sold All | -93,808 | -100 % | | | | 5.92 % | $-61,913 | | | | | | News Article | History of Dnb Asset Management Us Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fiduciary Asset Management Co | Institution | 49,700 | Sold Some | -49,930 | -50.11 % | $553,658 | $586,460 | $32,802 | 5.92 % | $-32,954 | | | | | | News Article | History of Fiduciary Asset Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Investors Management Co Inc | Institution | 277,900 | New Holding | 277,900 | 100 % | $3,095,806 | $3,279,220 | $183,414 | 5.92 % | $183,414 | | | | | | News Article | History of First Investors Management Co Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 68,400 | No Change | 0 | 0 % | $761,976 | $807,120 | $45,144 | 5.92 % | $0 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 6,402 | Sold Some | -364,226 | -98.27 % | $71,318 | $75,544 | $4,225 | 5.92 % | $-240,389 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 1,210,009 | Sold Some | -16,380 | -1.33 % | $13,479,500 | $14,278,106 | $798,606 | 5.92 % | $-10,811 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 1,553,843 | Added More | 773,242 | 99.05 % | $17,309,811 | $18,335,347 | $1,025,536 | 5.92 % | $510,340 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Grantham Mayo Van Otterloo And Co Llc | Institution | 130,400 | Sold Some | -158,600 | -54.87 % | $1,452,656 | $1,538,720 | $86,064 | 5.92 % | $-104,676 | | | | | | News Article | History of Grantham Mayo Van Otterloo And Co Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hbk Investments L P | Institution | 168,789 | Sold Some | -148,111 | -46.73 % | $1,880,309 | $1,991,710 | $111,401 | 5.92 % | $-97,753 | | | | | | News Article | History of Hbk Investments L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hotchkis And Wiley Capital Management Llc | Institution | 8,810,600 | Added More | 198,200 | 2.30 % | $98,150,084 | $103,965,080 | $5,814,996 | 5.92 % | $130,812 | | | | | | News Article | History of Hotchkis And Wiley Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | 3,015,569 | Sold Some | -447,000 | -12.90 % | $33,593,439 | $35,583,714 | $1,990,276 | 5.92 % | $-295,020 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 41,565 | Sold Some | -5,935 | -12.49 % | $463,034 | $490,467 | $27,433 | 5.92 % | $-3,917 | | | | | | News Article | History of Jefferies Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Keybank National Association | Institution | 14,429 | Sold Some | -254 | -1.72 % | $160,739 | $170,262 | $9,523 | 5.92 % | $-168 | | | | | | News Article | History of Keybank National Association Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Labranche And Co Inc | Institution | | Sold All | -14,947 | -100 % | | | | 5.92 % | $-9,865 | | | | | | News Article | History of Labranche And Co Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 110,910 | New Holding | 110,910 | 100 % | $1,235,537 | $1,308,738 | $73,201 | 5.92 % | $73,201 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 448,342 | Sold Some | -141,816 | -24.03 % | $4,994,530 | $5,290,436 | $295,906 | 5.92 % | $-93,599 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Marshall Ilsley Corp | Institution | 152,981 | Sold Some | -7,700 | -4.79 % | $1,704,208 | $1,805,176 | $100,967 | 5.92 % | $-5,082 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 49,405 | Sold Some | -177,630 | -78.23 % | $550,372 | $582,979 | $32,607 | 5.92 % | $-117,236 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mason Street Advisors Llc | Institution | 50,272 | Sold Some | -9,394 | -15.74 % | $560,030 | $593,210 | $33,180 | 5.92 % | $-6,200 | | | | | | News Article | History of Mason Street Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Natixis | Institution | 40,702 | Sold Some | -136 | -0.33 % | $453,420 | $480,284 | $26,863 | 5.92 % | $-90 | | | | | | News Article | History of Natixis Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 991,003 | Added More | 6,654 | 0.67 % | $11,039,773 | $11,693,835 | $654,062 | 5.92 % | $4,392 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 157,479 | Sold Some | -10,703 | -6.36 % | $1,754,316 | $1,858,252 | $103,936 | 5.92 % | $-7,064 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Pergamon Offshore Advisors L P | Institution | 240,888 | Sold Some | -35,703 | -12.90 % | $2,683,492 | $2,842,478 | $158,986 | 5.92 % | $-23,564 | | | | | | News Article | History of Pergamon Offshore Advisors L P Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Polar Capital Llp | Institution | 90,000 | Added More | 8,273 | 10.12 % | $1,002,600 | $1,062,000 | $59,400 | 5.92 % | $5,460 | | | | | | News Article | History of Polar Capital Llp Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 726,266 | Sold Some | -9,400 | -1.27 % | $8,090,603 | $8,569,939 | $479,336 | 5.92 % | $-6,204 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Public Sector Pension Investment Board | Institution | 18,359 | New Holding | 18,359 | 100 % | $204,519 | $216,636 | $12,117 | 5.92 % | $12,117 | | | | | | News Article | History of Public Sector Pension Investment Board Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 295,873 | Sold Some | -19,575 | -6.20 % | $3,296,025 | $3,491,301 | $195,276 | 5.92 % | $-12,920 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 2,880 | Sold Some | -8,925 | -75.60 % | $32,083 | $33,984 | $1,901 | 5.92 % | $-5,891 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 773,100 | Sold Some | -1,638,500 | -67.94 % | $8,612,334 | $9,122,580 | $510,246 | 5.92 % | $-1,081,410 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Research Affiliates Llc | Institution | 27,452 | Sold Some | -877 | -3.09 % | $305,815 | $323,934 | $18,118 | 5.92 % | $-579 | | | | | | News Article | History of Research Affiliates Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 50,465 | Sold Some | -135,735 | -72.89 % | $562,180 | $595,487 | $33,307 | 5.92 % | $-89,585 | | | | | | News Article | History of Sei Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 160,257 | Added More | 111,347 | 227.65 % | $1,785,263 | $1,891,033 | $105,770 | 5.92 % | $73,489 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sterling Capital Management Llc | No Data | 2,361,312 | Added More | 564,860 | 31.44 % | $26,305,016 | $27,863,482 | $1,558,466 | 5.92 % | $372,808 | | | | | | News Article | History of Sterling Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Symons Capital Management Inc | Institution | 31,130 | No Change | 0 | 0 % | $346,788 | $367,334 | $20,546 | 5.92 % | $0 | | | | | | News Article | History of Symons Capital Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Thompson Siegel And Walmsley Inc | Institution | 1,308,533 | Added More | 584,643 | 80.76 % | $14,577,058 | $15,440,689 | $863,632 | 5.92 % | $385,864 | | | | | | News Article | History of Thompson Siegel And Walmsley Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Van Den Berg Management Inc Tx | Institution | | Sold All | -18,700 | -100 % | | | | 5.92 % | $-12,342 | | | | | | News Article | History of Van Den Berg Management Inc Tx Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 11,463,373 | Added More | 283,427 | 2.53 % | $127,701,975 | $135,267,801 | $7,565,826 | 5.92 % | $187,062 | | | | | | News Article | History of Vanguard Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Wolverine Asset Management Llc | Institution | 80,126 | Sold Some | -73,187 | -47.73 % | $892,604 | $945,487 | $52,883 | 5.92 % | $-48,303 | | | | | | News Article | History of Wolverine Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 110,312 | Added More | 7,200 | 6.98 % | $1,234,391 | $1,301,682 | $67,290 | 5.45 % | $4,392 | | | | | | News Article | History of Td Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Agf Funds Inc | Institution | 2,503 | Added More | 653 | 35.29 % | $28,009 | $29,535 | $1,527 | 5.45 % | $398 | | | | | | News Article | History of Agf Funds Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Insurance Co | Institution | 11,239 | New Holding | 11,239 | 100 % | $125,764 | $132,620 | $6,856 | 5.45 % | $6,856 | | | | | | News Article | History of Allstate Insurance Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | American Assets Investment Management Llc | Institution | 50,000 | No Change | 0 | 0 % | $559,500 | $590,000 | $30,500 | 5.45 % | $0 | | | | | | News Article | History of American Assets Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Arrow Investment Advisors Llc | No Data | | Sold All | -14,650 | -100 % | | | | 5.45 % | $-8,937 | | | | | | News Article | History of Arrow Investment Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aviva Plc | Institution | 388,802 | Sold Some | -2,861 | -0.73 % | $4,350,694 | $4,587,864 | $237,169 | 5.45 % | $-1,745 | | | | | | News Article | History of Aviva Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 164,154 | Sold Some | -10,673 | -6.10 % | $1,836,883 | $1,937,017 | $100,134 | 5.45 % | $-6,511 | | | | | | News Article | History of Bank Of America Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 12,093,737 | Added More | 2,732,500 | 29.18 % | $135,328,917 | $142,706,097 | $7,377,180 | 5.45 % | $1,666,825 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 575,000 | New Holding | 575,000 | 100 % | $6,434,250 | $6,785,000 | $350,750 | 5.45 % | $350,750 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Brandes Investment Partners Lp | Institution | 1,524,254 | Added More | 635,592 | 71.52 % | $17,056,402 | $17,986,197 | $929,795 | 5.45 % | $387,711 | | | | | | News Article | History of Brandes Investment Partners Lp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Canada Pension Plan Investment Board | Institution | | Sold All | -3,081 | -100 % | | | | 5.45 % | $-1,879 | | | | | | News Article | History of Canada Pension Plan Investment Board Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Catalyst Investment Management Co Llc | Institution | 125,000 | New Holding | 125,000 | 100 % | $1,398,750 | $1,475,000 | $76,250 | 5.45 % | $76,250 | | | | | | News Article | History of Catalyst Investment Management Co Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | | Sold All | -148,950 | -100 % | | | | 5.45 % | $-90,860 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chou Associates Management Inc | Institution | 7,236,100 | No Change | 0 | 0 % | $80,971,959 | $85,385,980 | $4,414,021 | 5.45 % | $0 | | | | | | News Article | History of Chou Associates Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Clark Estates Inc | Institution | 72,000 | No Change | 0 | 0 % | $805,680 | $849,600 | $43,920 | 5.45 % | $0 | | | | | | News Article | History of Clark Estates Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Claymore Advisors Llc | Institution | | Sold All | -10,141 | -100 % | | | | 5.45 % | $-6,186 | | | | | | News Article | History of Claymore Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 49,077 | New Holding | 49,077 | 100 % | $549,172 | $579,109 | $29,937 | 5.45 % | $29,937 | | | | | | News Article | History of Credit Suisse Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 355 | New Holding | 355 | 100 % | $3,972 | $4,189 | $217 | 5.45 % | $217 | | | | | | News Article | History of Davidson D A And Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 355 | New Holding | 355 | 100 % | $3,972 | $4,189 | $217 | 5.45 % | $217 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Diamond Hill Capital Management Inc | Institution | 1,149,595 | New Holding | 1,149,595 | 100 % | $12,863,968 | $13,565,221 | $701,253 | 5.45 % | $701,253 | | | | | | News Article | History of Diamond Hill Capital Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Diversified Global Asset Management Corp | Institution | 11,810 | New Holding | 11,810 | 100 % | $132,154 | $139,358 | $7,204 | 5.45 % | $7,204 | | | | | | News Article | History of Diversified Global Asset Management Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fairfax Financial Holdings Ltd Can | Institution | | Sold All | -8,317,500 | -100 % | | | | 5.45 % | $-5,073,675 | | | | | | News Article | History of Fairfax Financial Holdings Ltd Can Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 502,368 | No Change | 0 | 0 % | $5,621,498 | $5,927,942 | $306,444 | 5.45 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gamco Investors Inc Et Al | Institution | 10,000 | No Change | 0 | 0 % | $111,900 | $118,000 | $6,100 | 5.45 % | $0 | | | | | | News Article | History of Gamco Investors Inc Et Al Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Great West Life Assurance Co | Institution | 384,217 | No Change | 0 | 0 % | $4,299,388 | $4,533,761 | $234,372 | 5.45 % | $0 | | | | | | News Article | History of Great West Life Assurance Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gsa Capital Partners Llp | Institution | | Sold All | -22,239 | -100 % | | | | 5.45 % | $-13,566 | | | | | | News Article | History of Gsa Capital Partners Llp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Hbos Plc | No Data | 45,827 | Added More | 9,212 | 25.15 % | $512,804 | $540,759 | $27,954 | 5.45 % | $5,619 | | | | | | News Article | History of Hbos Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 200,167 | Sold Some | -166,156 | -45.35 % | $2,239,869 | $2,361,971 | $122,102 | 5.45 % | $-101,355 | | | | | | News Article | History of Ing Investment Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Irish Life Investment Managers | Institution | 83,866 | Added More | 9,200 | 12.32 % | $938,461 | $989,619 | $51,158 | 5.45 % | $5,612 | | | | | | News Article | History of Irish Life Investment Managers Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 6,200 | Sold Some | -3,872 | -38.44 % | $69,378 | $73,160 | $3,782 | 5.45 % | $-2,362 | | | | | | News Article | History of Kbc Group Nv Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Legal And General Group Plc | Institution | 914,443 | Added More | 162,325 | 21.58 % | $10,232,617 | $10,790,427 | $557,810 | 5.45 % | $99,018 | | | | | | News Article | History of Legal And General Group Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Lsv Asset Management | Institution | 10,046,334 | Added More | 109,000 | 1.09 % | $112,418,477 | $118,546,741 | $6,128,264 | 5.45 % | $66,490 | | | | | | News Article | History of Lsv Asset Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Manufactureres Life Insurance Co | Institution | 45,932 | Sold Some | -25,496 | -35.69 % | $513,979 | $541,998 | $28,019 | 5.45 % | $-15,553 | | | | | | News Article | History of Manufactureres Life Insurance Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Marco Investment Management Llc | Institution | 1,715 | Added More | 1,199 | 232.36 % | $19,191 | $20,237 | $1,046 | 5.45 % | $731 | | | | | | News Article | History of Marco Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 823,788 | Added More | 100,952 | 13.96 % | $9,218,188 | $9,720,698 | $502,511 | 5.45 % | $61,581 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 215,286 | Sold Some | -1,795 | -0.82 % | $2,409,050 | $2,540,375 | $131,324 | 5.45 % | $-1,095 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 90 | Sold Some | -2,600 | -96.65 % | $1,007 | $1,062 | $55 | 5.45 % | $-1,586 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Singapore Ltd | No Data | 3,600 | No Change | 0 | 0 % | $40,284 | $42,480 | $2,196 | 5.45 % | $0 | | | | | | News Article | History of Nomura Asset Management Singapore Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 471,005 | Added More | 158,434 | 50.68 % | $5,270,546 | $5,557,859 | $287,313 | 5.45 % | $96,645 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 7,920 | Added More | 2,260 | 39.92 % | $88,625 | $93,456 | $4,831 | 5.45 % | $1,379 | | | | | | News Article | History of Padco Advisors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 160,978 | Added More | 2,699 | 1.70 % | $1,801,344 | $1,899,540 | $98,197 | 5.45 % | $1,646 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Qa3 Financial Llc | No Data | 70 | Sold Some | -630 | -90.00 % | $783 | $826 | $43 | 5.45 % | $-384 | | | | | | News Article | History of Qa3 Financial Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Redstone Investment Management Lp | Institution | | Sold All | -52,300 | -100 % | | | | 5.45 % | $-31,903 | | | | | | News Article | History of Redstone Investment Management Lp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 24,468 | Added More | 3,320 | 15.69 % | $273,797 | $288,722 | $14,925 | 5.45 % | $2,025 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 2,487,308 | Sold Some | -247,590 | -9.05 % | $27,832,977 | $29,350,234 | $1,517,258 | 5.45 % | $-151,030 | | | | | | News Article | History of Russell Frank Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Barbara Asset Management | Institution | 4,460 | Sold Some | -9,218 | -67.39 % | $49,907 | $52,628 | $2,721 | 5.45 % | $-5,623 | | | | | | News Article | History of Santa Barbara Asset Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Fe Partners Llc | Institution | | Sold All | -11,922 | -100 % | | | | 5.45 % | $-7,272 | | | | | | News Article | History of Santa Fe Partners Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 970,000 | No Compare | | | $10,854,300 | $11,446,000 | $591,700 | 5.45 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Signaturefd Llc | No Data | | Sold All | -190 | -100 % | | | | 5.45 % | $-116 | | | | | | News Article | History of Signaturefd Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 10,053 | Sold Some | -2,826 | -21.94 % | $112,493 | $118,625 | $6,132 | 5.45 % | $-1,724 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 72,904 | Added More | 30,271 | 71.00 % | $815,796 | $860,267 | $44,471 | 5.45 % | $18,465 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 60,400 | Sold Some | -21,000 | -25.79 % | $675,876 | $712,720 | $36,844 | 5.45 % | $-12,810 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | 36,120 | Sold Some | -9,380 | -20.61 % | $404,183 | $426,216 | $22,033 | 5.45 % | $-5,722 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 123,740 | Sold Some | -145,960 | -54.11 % | $1,384,651 | $1,460,132 | $75,481 | 5.45 % | $-89,036 | | | | | | News Article | History of United Services Automobile Association Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 152,896 | Added More | 72,500 | 90.17 % | $1,710,906 | $1,804,173 | $93,267 | 5.45 % | $44,225 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | West Chester Capital Advisors Inc | Institution | 25,096 | No Change | 0 | 0 % | $280,824 | $296,133 | $15,309 | 5.45 % | $0 | | | | | | News Article | History of West Chester Capital Advisors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 57,534 | Added More | 3,665 | 6.80 % | $643,805 | $678,901 | $35,096 | 5.45 % | $2,236 | | | | | | News Article | History of World Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 473,671 | Sold Some | -1,003,765 | -67.93 % | $5,314,589 | $5,589,318 | $274,729 | 5.16 % | $-582,184 | | | | | | News Article | History of American Century Companies Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 462,506 | Sold Some | -149,238 | -24.39 % | $5,189,317 | $5,457,571 | $268,253 | 5.16 % | $-86,558 | | | | | | News Article | History of Citigroup Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Clarivest Asset Management Llc | Institution | 223,526 | Sold Some | -287,720 | -56.27 % | $2,507,962 | $2,637,607 | $129,645 | 5.16 % | $-166,878 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 123,624 | Sold Some | -44,916 | -26.65 % | $1,387,061 | $1,458,763 | $71,702 | 5.16 % | $-26,051 | | | | | | News Article | History of Comerica Bank Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dlibj Asset Management Co Ltd | Institution | 17,157 | Sold Some | -111,350 | -86.64 % | $192,502 | $202,453 | $9,951 | 5.16 % | $-64,583 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | First National Trust Co | Institution | 3,792 | Added More | 219 | 6.12 % | $42,546 | $44,746 | $2,199 | 5.16 % | $127 | | | | | | News Article | History of First National Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 25,886 | Added More | 1,011 | 4.06 % | $290,441 | $305,455 | $15,014 | 5.16 % | $586 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 117,374 | New Holding | 117,374 | 100 % | $1,316,936 | $1,385,013 | $68,077 | 5.16 % | $68,077 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ig Investment Management Ltd | Institution | 27,080 | Added More | 17,560 | 184.45 % | $303,838 | $319,544 | $15,706 | 5.16 % | $10,185 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 851,452 | Added More | 165,138 | 24.06 % | $9,553,291 | $10,047,134 | $493,842 | 5.16 % | $95,780 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Pax World Management Corp | Institution | 66,000 | Added More | 6,000 | 10.00 % | $740,520 | $778,800 | $38,280 | 5.16 % | $3,480 | | | | | | News Article | History of Pax World Management Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Platte River Capital Llc | Institution | 88,910 | New Holding | 88,910 | 100 % | $997,570 | $1,049,138 | $51,568 | 5.16 % | $51,568 | | | | | | News Article | History of Platte River Capital Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | | Sold All | -6,500 | -100 % | | | | 5.16 % | $-3,770 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 484,958 | Added More | 17,345 | 3.70 % | $5,441,229 | $5,722,504 | $281,276 | 5.16 % | $10,060 | | | | | | News Article | History of Ubs Ag Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Verizon Communications Inc | Institution | 72,000 | No Change | 0 | 0 % | $807,840 | $849,600 | $41,760 | 5.16 % | $0 | | | | | | News Article | History of Verizon Communications Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-08-31 | N-CSR | Morgan Stanley S And P 500 Index Fund - None | Specialty & Misc | 16,859 | No Change | 0 | 0 % | $189,158 | $198,936 | $9,778 | 5.16 % | $0 | | | | | | News Article | History of Morgan Stanley S And P 500 Index Fund - None Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-06-30 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 128,507 | Added More | 59,550 | 86.35 % | $1,441,849 | $1,516,383 | $74,534 | 5.16 % | $34,539 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-03-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 68,957 | Sold Some | -23,500 | -25.41 % | $773,698 | $813,693 | $39,995 | 5.16 % | $-13,630 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2009-03-31 | 13F-HR/A | Yale Capital Corp | Institution | 15,000 | No Change | 0 | 0 % | $168,300 | $177,000 | $8,700 | 5.16 % | $0 | | | | | | News Article | History of Yale Capital Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-10 | 2008-12-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 92,457 | Added More | 39,000 | 72.95 % | $1,037,368 | $1,090,993 | $53,625 | 5.16 % | $22,620 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 25,337 | No Change | 0 | 0 % | $289,349 | $298,977 | $9,628 | 3.32 % | $0 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Bridgewater Associates Inc | Institution | 703,396 | Added More | 222,800 | 46.35 % | $8,032,782 | $8,300,073 | $267,290 | 3.32 % | $84,664 | | | | | | News Article | History of Bridgewater Associates Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Cambiar Investors Llc | Institution | 116,545 | Added More | 37,216 | 46.91 % | $1,330,944 | $1,375,231 | $44,287 | 3.32 % | $14,142 | | | | | | News Article | History of Cambiar Investors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 2,430 | No Change | 0 | 0 % | $27,751 | $28,674 | $923 | 3.32 % | $0 | | | | | | News Article | History of Ccm Partners Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Cibc World Markets Corp | Institution | 73,762 | Added More | 43,832 | 146.44 % | $842,362 | $870,392 | $28,030 | 3.32 % | $16,656 | | | | | | News Article | History of Cibc World Markets Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 2,906 | Sold Some | -319,025 | -99.09 % | $33,187 | $34,291 | $1,104 | 3.32 % | $-121,230 | | | | | | News Article | History of Federated Investors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | General Motors Investment Management Corp | Institution | | Sold All | -33,362 | -100 % | | | | 3.32 % | $-12,678 | | | | | | News Article | History of General Motors Investment Management Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Goldman Jay G | Institution | 180,000 | Added More | 15,000 | 9.09 % | $2,055,600 | $2,124,000 | $68,400 | 3.32 % | $5,700 | | | | | | News Article | History of Goldman Jay G Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ifrah Financial Services Inc | Institution | 29,567 | Sold Some | -2,618 | -8.13 % | $337,655 | $348,891 | $11,235 | 3.32 % | $-995 | | | | | | News Article | History of Ifrah Financial Services Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 366,582 | No Compare | | | $4,186,366 | $4,325,668 | $139,301 | 3.32 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | | Sold All | -62,000 | -100 % | | | | 3.32 % | $-23,560 | | | | | | News Article | History of Numeric Investors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Piper Jaffray Companies | Institution | | Sold All | -65 | -100 % | | | | 3.32 % | $-25 | | | | | | News Article | History of Piper Jaffray Companies Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 218,997 | Added More | 20,196 | 10.15 % | $2,500,946 | $2,584,165 | $83,219 | 3.32 % | $7,674 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Twin Capital Management Inc | Institution | 38,900 | Added More | 50 | 0.12 % | $444,238 | $459,020 | $14,782 | 3.32 % | $19 | | | | | | News Article | History of Twin Capital Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Vtl Associates Llc | Institution | | Sold All | -47 | -100 % | | | | 3.32 % | $-18 | | | | | | News Article | History of Vtl Associates Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-08-31 | N-CSR | American Performance Funds - Balanced Fund | Flexible Portfolio | | Sold All | -1,030 | -100 % | | | | 3.32 % | $-391 | | | | | | News Article | History of American Performance Funds - Balanced Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-09 | 2009-08-31 | N-CSRS | Jpmorgan Institutional Trust - Jpmorgan Equity Index Trust | Specialty & Misc | | Sold All | -9 | -100 % | | | | 3.32 % | $-3 | | | | | | News Article | History of Jpmorgan Institutional Trust - Jpmorgan Equity Index Trust Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Deere And Co | Institution | 48,173 | Sold Some | -26,620 | -35.59 % | $540,019 | $568,441 | $28,422 | 5.26 % | $-15,706 | | | | | | News Article | History of Deere And Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 69,650 | Sold Some | -2,600 | -3.59 % | $780,777 | $821,870 | $41,094 | 5.26 % | $-1,534 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 207,054 | Sold Some | -7,307 | -3.40 % | $2,321,075 | $2,443,237 | $122,162 | 5.26 % | $-4,311 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 146 | Sold Some | -43,584 | -99.66 % | $1,637 | $1,723 | $86 | 5.26 % | $-25,715 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 2,193,153 | Sold Some | -408,235 | -15.69 % | $24,585,245 | $25,879,205 | $1,293,960 | 5.26 % | $-240,859 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 1,791,265 | Added More | 72,629 | 4.22 % | $20,080,081 | $21,136,927 | $1,056,846 | 5.26 % | $42,851 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 7,395,148 | Sold Some | -1,370,174 | -15.63 % | $82,899,609 | $87,262,746 | $4,363,137 | 5.26 % | $-808,403 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Rbb Fund Inc - Senbanc Fund | Financial Services | 61,500 | New Holding | 61,500 | 100 % | $689,415 | $725,700 | $36,285 | 5.26 % | $36,285 | | | | | | News Article | History of Rbb Fund Inc - Senbanc Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 4,977 | Added More | 1,508 | 43.47 % | $53,453 | $58,729 | $5,276 | 9.86 % | $1,598 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Guardian Investor Services Llc | Institution | 6,872 | No Change | 0 | 0 % | $73,805 | $81,090 | $7,284 | 9.86 % | $0 | | | | | | News Article | History of Guardian Investor Services Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 50,676 | Sold Some | -5,000 | -8.98 % | $544,260 | $597,977 | $53,717 | 9.86 % | $-5,300 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 366,861 | Added More | 4,342 | 1.19 % | $3,940,087 | $4,328,960 | $388,873 | 9.86 % | $4,603 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 17,395 | Sold Some | -1,092 | -5.90 % | $186,822 | $205,261 | $18,439 | 9.86 % | $-1,158 | | | | | | News Article | History of Profund Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 45,596 | Sold Some | -29,374 | -39.18 % | $489,701 | $538,033 | $48,332 | 9.86 % | $-31,136 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Tal Global Asset Management Inc | Institution | 27,580 | Sold Some | -3,398 | -10.96 % | $296,209 | $325,444 | $29,235 | 9.86 % | $-3,602 | | | | | | News Article | History of Tal Global Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 88,404 | Sold Some | -146,392 | -62.34 % | $949,459 | $1,043,167 | $93,708 | 9.86 % | $-155,176 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Value Line Inc | Institution | 27,400 | No Change | 0 | 0 % | $294,276 | $323,320 | $29,044 | 9.86 % | $0 | | | | | | News Article | History of Value Line Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Wcm Investment Management | Institution | 646,183 | New Holding | 646,183 | 100 % | $6,940,005 | $7,624,959 | $684,954 | 9.86 % | $684,954 | | | | | | News Article | History of Wcm Investment Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf | Specialty & Misc | 273 | No Change | 0 | 0 % | $2,932 | $3,221 | $289 | 9.86 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Babson Capital Management Llc | Institution | 66,810 | No Change | 0 | 0 % | $680,794 | $788,358 | $107,564 | 15.79 % | $0 | | | | | | News Article | History of Babson Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Botti Brown Asset Management Llc | Institution | | Sold All | -466,100 | -100 % | | | | 15.79 % | $-750,421 | | | | | | News Article | History of Botti Brown Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Capital One National Association | Institution | 78,574 | Added More | 1,240 | 1.60 % | $800,669 | $927,173 | $126,504 | 15.79 % | $1,996 | | | | | | News Article | History of Capital One National Association Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | First Community Bank Trust And Financial Services Divison | Institution | 10,000 | No Change | 0 | 0 % | $101,900 | $118,000 | $16,100 | 15.79 % | $0 | | | | | | News Article | History of First Community Bank Trust And Financial Services Divison Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 26,487 | No Change | 0 | 0 % | $269,903 | $312,547 | $42,644 | 15.79 % | $0 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Ims Capital Management | Institution | 292,011 | Sold Some | -83,811 | -22.30 % | $2,975,592 | $3,445,730 | $470,138 | 15.79 % | $-134,936 | | | | | | News Article | History of Ims Capital Management Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Lehrer Management Co Inc | Institution | 18,050 | New Holding | 18,050 | 100 % | $183,930 | $212,990 | $29,061 | 15.79 % | $29,061 | | | | | | News Article | History of Lehrer Management Co Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 30,051 | New Holding | 30,051 | 100 % | $306,220 | $354,602 | $48,382 | 15.79 % | $48,382 | | | | | | News Article | History of Tradeworx Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -77,600 | -100 % | | | | 15.79 % | $-124,936 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | King Luther Capital Management Corp | Institution | | Sold All | -17,600 | -100 % | | | | 15.00 % | $-27,104 | | | | | | News Article | History of King Luther Capital Management Corp Ownership Of King Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 1,753,482 | Added More | 83,987 | 5.03 % | $17,990,725 | $20,691,088 | $2,700,362 | 15.00 % | $129,340 | | | | | | News Article | History of Prudential Financial Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Management Llc | Institution | 19,980 | Added More | 2,710 | 15.69 % | $204,995 | $235,764 | $30,769 | 15.00 % | $4,173 | | | | | | News Article | History of Turner Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 1,370,694 | Sold Some | -34,747 | -2.47 % | $14,063,320 | $16,174,189 | $2,110,869 | 15.00 % | $-53,510 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of King Pharmaceuticals Inc |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - S And P 500 Index Fund | S&P 500 Index | 2,430 | No Change | 0 | 0 % | $24,932 | $28,674 | $3,742 | 15.00 % | $0 | | | | | | News Article | History of California Investment Trust - S And P 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Advanced Investment Partners Llc | No Data | 78,797 | Added More | 1,821 | 2.36 % | $802,941 | $929,805 | $126,863 | 15.79 % | $2,932 | | | | | | News Article | History of Advanced Investment Partners Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | First New York Securities Llc | Institution | | Sold All | -10,200 | -100 % | | | | 15.79 % | $-16,422 | | | | | | News Article | History of First New York Securities Llc Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 288,233 | Sold Some | -276,633 | -48.97 % | $2,937,094 | $3,401,149 | $464,055 | 15.79 % | $-445,379 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | 1,641,800 | Added More | 823,500 | 100.63 % | $16,729,942 | $19,373,240 | $2,643,298 | 15.79 % | $1,325,835 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 139,100 | Added More | 31,500 | 29.27 % | $1,417,429 | $1,641,380 | $223,951 | 15.79 % | $50,715 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-06-30 | 13F-HR/A | Yale Capital Corp | Institution | 15,000 | No Change | 0 | 0 % | $152,850 | $177,000 | $24,150 | 15.79 % | $0 | | | | | | News Article | History of Yale Capital Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Clinton Group Inc | Institution | | Sold All | -12,742 | -100 % | | | | 16.48 % | $-21,279 | | | | | | News Article | History of Clinton Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Old National Bancorp | Institution | 21,544 | Added More | 4,600 | 27.14 % | $218,241 | $254,219 | $35,978 | 16.48 % | $7,682 | | | | | | News Article | History of Old National Bancorp Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 151,666 | Sold Some | -20,793 | -12.05 % | $1,536,377 | $1,789,659 | $253,282 | 16.48 % | $-34,724 | | | | | | News Article | History of Oxford Asset Management Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Texas Permanent School Fund | Institution | 213,334 | Sold Some | -693 | -0.32 % | $2,161,073 | $2,517,341 | $356,268 | 16.48 % | $-1,157 | | | | | | News Article | History of Texas Permanent School Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 455,500 | Added More | 49,097 | 12.08 % | $4,614,215 | $5,374,900 | $760,685 | 16.48 % | $81,992 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Yale Capital Corp | Institution | 15,000 | No Change | 0 | 0 % | $151,950 | $177,000 | $25,050 | 16.48 % | $0 | | | | | | News Article | History of Yale Capital Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Balanced Fund | Mixed-Asset Target Allocation Moderate | 154,362 | Added More | 114,462 | 286.87 % | $1,563,687 | $1,821,472 | $257,785 | 16.48 % | $191,152 | | | | | | News Article | History of Fidelity Advisor Series I - Balanced Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 24,600 | New Holding | 24,600 | 100 % | $249,198 | $290,280 | $41,082 | 16.48 % | $41,082 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Value Strategies | Multi-Cap Core | 541,400 | Added More | 499,800 | 1201.44 % | $5,484,382 | $6,388,520 | $904,138 | 16.48 % | $834,666 | | | | | | News Article | History of Fidelity Advisor Series I - Value Strategies Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Large Cap Value Enhanced Index Fund | Large-Cap Value | | Sold All | -7,584 | -100 % | | | | 16.48 % | $-12,665 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Large Cap Value Enhanced Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Sei Institutional Investments Trust - Siit Large Cap Fund | Large-Cap Core | | Sold All | -56,700 | -100 % | | | | 16.48 % | $-94,689 | | | | | | News Article | History of Sei Institutional Investments Trust - Siit Large Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Ftse Social Index Fund | Large-Cap Core | 30,969 | Sold Some | -1,308 | -4.05 % | $313,716 | $365,434 | $51,718 | 16.48 % | $-2,184 | | | | | | News Article | History of Vanguard World Fund - Vanguard Ftse Social Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 112,436 | Sold Some | -4,244 | -3.63 % | $1,138,977 | $1,326,745 | $187,768 | 16.48 % | $-7,087 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 4,668,591 | Sold Some | -61,763 | -1.30 % | $48,179,859 | $55,089,374 | $6,909,515 | 14.34 % | $-91,409 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lyz Capital Advisors Llc | Institution | 29,832 | Sold Some | -800 | -2.61 % | $307,866 | $352,018 | $44,151 | 14.34 % | $-1,184 | | | | | | News Article | History of Lyz Capital Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Seizert Capital Partners Llc | Institution | 484,621 | Sold Some | -32,975 | -6.37 % | $5,001,289 | $5,718,528 | $717,239 | 14.34 % | $-48,803 | | | | | | News Article | History of Seizert Capital Partners Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Dreyfus Premier Manager Funds Ii - Balanced Opportunity Fund | Mixed-Asset Target Allocation Growth | 51,260 | New Holding | 51,260 | 100 % | $529,003 | $604,868 | $75,865 | 14.34 % | $75,865 | | | | | | News Article | History of Dreyfus Premier Manager Funds Ii - Balanced Opportunity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Fund | Specialty & Misc | 7,216 | Sold Some | -23,515 | -76.51 % | $74,469 | $85,149 | $10,680 | 14.34 % | $-34,802 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Value Fund | Multi-Cap Value | 22,505 | Sold Some | -802 | -3.44 % | $232,252 | $265,559 | $33,307 | 14.34 % | $-1,187 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Equity Series Inc - Riversource Mid Cap Growth Fund | Mid-Cap Growth | 242,168 | New Holding | 242,168 | 100 % | $2,499,174 | $2,857,582 | $358,409 | 14.34 % | $358,409 | | | | | | News Article | History of Riversource Equity Series Inc - Riversource Mid Cap Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -100 | -100 % | | | | 14.34 % | $-148 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 24,400 | New Holding | 24,400 | 100 % | $251,808 | $287,920 | $36,112 | 14.34 % | $36,112 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Chevy Chase Trust Holdings Inc | No Data | 236,551 | Sold Some | -7,076 | -2.90 % | $2,358,413 | $2,791,302 | $432,888 | 18.35 % | $-12,949 | | | | | | News Article | History of Chevy Chase Trust Holdings Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Global Equity Llc | Institution | 28,400 | New Holding | 28,400 | 100 % | $283,148 | $335,120 | $51,972 | 18.35 % | $51,972 | | | | | | News Article | History of Global Equity Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Guaranty Trust Co Of Missouri | Institution | 1,000 | New Holding | 1,000 | 100 % | $9,970 | $11,800 | $1,830 | 18.35 % | $1,830 | | | | | | News Article | History of Guaranty Trust Co Of Missouri Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Thunderstorm Capital Llc | Institution | | Sold All | -121,080 | -100 % | | | | 18.35 % | $-221,576 | | | | | | News Article | History of Thunderstorm Capital Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century Strategic Asset Allocations Inc - Newton Fund | Small-Cap Core | 67,632 | Sold Some | -192,861 | -74.03 % | $674,291 | $798,058 | $123,767 | 18.35 % | $-352,936 | | | | | | News Article | History of American Century Strategic Asset Allocations Inc - Newton Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-CSRS | Fidelity Concord Street Trust - Spartan International Index Fund | Global Flex Port | | Sold All | -566,218 | -100 % | | | | 18.35 % | $-1,036,179 | | | | | | News Article | History of Fidelity Concord Street Trust - Spartan International Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Dupont Capital Management | Institution | 304,800 | New Holding | 304,800 | 100 % | $3,172,968 | $3,596,640 | $423,672 | 13.35 % | $423,672 | | | | | | News Article | History of Dupont Capital Management Ownership Of King Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 103,801 | New Holding | 103,801 | 100 % | $1,080,568 | $1,224,852 | $144,283 | 13.35 % | $144,283 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Parametric Risk Advisors Llc | Institution | 3,000 | No Change | 0 | 0 % | $31,230 | $35,400 | $4,170 | 13.35 % | $0 | | | | | | News Article | History of Parametric Risk Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Rivanna Capital Llc | Institution | 430,000 | New Holding | 430,000 | 100 % | $4,476,300 | $5,074,000 | $597,700 | 13.35 % | $597,700 | | | | | | News Article | History of Rivanna Capital Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR/A | Obermeyer Asset Management Co | Institution | 131 | No Change | 0 | 0 % | $1,353 | $1,546 | $193 | 14.23 % | $0 | | | | | | News Article | History of Obermeyer Asset Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | | Sold All | -46,163 | -100 % | | | | 14.23 % | $-67,860 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of King Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 131 | No Change | 0 | 0 % | $1,353 | $1,546 | $193 | 14.23 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of King Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 3,454,985 | Added More | 47,901 | 1.40 % | $35,689,995 | $40,768,823 | $5,078,828 | 14.23 % | $70,414 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Haberer Registered Investment Advisor Inc | Institution | 111 | No Change | 0 | 0 % | $1,152 | $1,310 | $158 | 13.68 % | $0 | | | | | | News Article | History of Haberer Registered Investment Advisor Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Veredus Asset Management Llc | Institution | 152,950 | Added More | 58,290 | 61.57 % | $1,587,621 | $1,804,810 | $217,189 | 13.68 % | $82,772 | | | | | | News Article | History of Veredus Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Wedbush Morgan Securities Inc | Institution | | Sold All | -10,500 | -100 % | | | | 13.68 % | $-14,910 | | | | | | News Article | History of Wedbush Morgan Securities Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 1,297,433 | Sold Some | -469,000 | -26.55 % | $13,947,405 | $15,309,709 | $1,362,305 | 9.76 % | $-492,450 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 197,700 | Sold Some | -39,400 | -16.61 % | $2,125,275 | $2,332,860 | $207,585 | 9.76 % | $-41,370 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 660,864 | Sold Some | -307,103 | -31.72 % | $7,104,288 | $7,798,195 | $693,907 | 9.76 % | $-322,458 | | | | | | News Article | History of Blackrock Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 727,100 | Added More | 81,280 | 12.58 % | $7,816,325 | $8,579,780 | $763,455 | 9.76 % | $85,344 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR/A | Ned Davis Research | Institution | 74,300 | Added More | 1,100 | 1.50 % | $798,725 | $876,740 | $78,015 | 9.76 % | $1,155 | | | | | | News Article | History of Ned Davis Research Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Oakbrook Investments Llc | Institution | 69,411 | Added More | 8,041 | 13.10 % | $746,168 | $819,050 | $72,882 | 9.76 % | $8,443 | | | | | | News Article | History of Oakbrook Investments Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Regions Financial Corp | Institution | 12,083 | No Change | 0 | 0 % | $129,892 | $142,579 | $12,687 | 9.76 % | $0 | | | | | | News Article | History of Regions Financial Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Robeco Institutional Asset Management Bv | Institution | | Sold All | -48,800 | -100 % | | | | 9.76 % | $-51,240 | | | | | | News Article | History of Robeco Institutional Asset Management Bv Ownership Of King Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 8,765,902 | Added More | 11,959 | 0.13 % | $94,145,787 | $103,437,644 | $9,291,856 | 9.86 % | $12,677 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 677,096 | Added More | 90,200 | 15.36 % | $7,272,011 | $7,989,733 | $717,722 | 9.86 % | $95,612 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of King Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 144,400 | No Change | 0 | 0 % | $1,579,736 | $1,703,920 | $124,184 | 7.86 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of King Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 416,316 | Added More | 122,790 | 41.83 % | $4,554,497 | $4,912,529 | $358,032 | 7.86 % | $105,599 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of King Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Royal London Asset Management Ltd | Institution | 42,404 | Added More | 183 | 0.43 % | $475,349 | $500,367 | $25,018 | 5.26 % | $108 | | | | | | News Article | History of Royal London Asset Management Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 581,000 | Sold Some | -19,700 | -3.27 % | $6,513,010 | $6,855,800 | $342,790 | 5.26 % | $-11,623 | | | | | | News Article | History of Strs Ohio Ownership Of King Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Tompkins Trustco Inc | Institution | | Sold All | -50 | -100 % | | | | 5.26 % | $-30 | | | | | | News Article | History of Tompkins Trustco Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 33,922 | No Change | 0 | 0 % | $375,177 | $400,280 | $25,102 | 6.69 % | $0 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Exxonmobil Investment Management Inc | Institution | 94,412 | Sold Some | -9,951 | -9.53 % | $1,054,582 | $1,114,062 | $59,480 | 5.64 % | $-6,269 | | | | | | News Article | History of Exxonmobil Investment Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 311,231 | Added More | 9,531 | 3.15 % | $3,476,450 | $3,672,526 | $196,076 | 5.64 % | $6,005 | | | | | | News Article | History of Harris Financial Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Nordea Investment Management Ab | Institution | 2,663 | No Change | 0 | 0 % | $29,746 | $31,423 | $1,678 | 5.64 % | $0 | | | | | | News Article | History of Nordea Investment Management Ab Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 833,928 | Added More | 207,870 | 33.20 % | $9,314,976 | $9,840,350 | $525,375 | 5.64 % | $130,958 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 15,192 | Added More | 210 | 1.40 % | $169,695 | $179,266 | $9,571 | 5.64 % | $132 | | | | | | News Article | History of Standard Life Investments Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 14,982 | No Change | 0 | 0 % | $167,349 | $176,788 | $9,439 | 5.64 % | $0 | | | | | | News Article | History of Standard Life Investments Ownership Of King Pharmaceuticals Inc |
| 2009-10-15 | 2008-06-30 | 13F-HR/A | Clarivest Asset Management Llc | Institution | 1,469,078 | Sold Some | -252,763 | -14.67 % | $16,409,601 | $17,335,120 | $925,519 | 5.64 % | $-159,241 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Alpha Windward Llc | Institution | | Sold All | -23,159 | -100 % | | | | 4.60 % | $-12,043 | | | | | | News Article | History of Alpha Windward Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | First Citizens Bank And Trust Co | Institution | 132,076 | Sold Some | -21,409 | -13.94 % | $1,489,817 | $1,558,497 | $68,680 | 4.60 % | $-11,133 | | | | | | News Article | History of First Citizens Bank And Trust Co Ownership Of King Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Independent Portfolio Consultants Inc | No Data | 15,690 | Added More | 210 | 1.35 % | $176,983 | $185,142 | $8,159 | 4.60 % | $109 | | | | | | News Article | History of Independent Portfolio Consultants Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Endex Capital Management Llc | Institution | 2,203 | Sold Some | -1,938 | -46.80 % | $23,947 | $25,995 | $2,049 | 8.55 % | $-1,802 | | | | | | News Article | History of Endex Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Meeder Asset Management Inc | Institution | 8,950 | Sold Some | -12,286 | -57.85 % | $93,617 | $105,610 | $11,993 | 12.81 % | $-16,463 | | | | | | News Article | History of Meeder Asset Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund | Health/Biotech | | Sold All | -16,154 | -100 % | | | | 12.81 % | $-21,646 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Large Cap Core Alphadex Fund | No Data | | Sold All | -3,687 | -100 % | | | | 12.81 % | $-4,941 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Large Cap Core Alphadex Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Large Cap Growth Opportunities Alphadex Fund | Large-Cap Growth | 2,728 | New Holding | 2,728 | 100 % | $28,535 | $32,190 | $3,656 | 12.81 % | $3,656 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Large Cap Growth Opportunities Alphadex Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | James Investment Research Inc | Institution | 37,200 | Sold Some | -4,700 | -11.21 % | $384,648 | $438,960 | $54,312 | 14.11 % | $-6,862 | | | | | | News Article | History of James Investment Research Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 466,052 | Added More | 6,732 | 1.46 % | $4,818,978 | $5,499,414 | $680,436 | 14.11 % | $9,829 | | | | | | News Article | History of Rhumbline Advisers Ownership Of King Pharmaceuticals Inc |
| 2009-10-08 | 2009-07-31 | N-CSR | Domini Social Investment Trust - Domini Social Equity Fund | Specialty & Misc | 355,100 | New Holding | 355,100 | 100 % | $3,671,734 | $4,190,180 | $518,446 | 14.11 % | $518,446 | | | | | | News Article | History of Domini Social Investment Trust - Domini Social Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-08 | 2008-07-31 | N-CSR | Morgan Stanley Health Sciences Trust - None | Specialty & Misc | 28,453 | New Holding | 28,453 | 100 % | $294,204 | $335,745 | $41,541 | 14.11 % | $41,541 | | | | | | News Article | History of Morgan Stanley Health Sciences Trust - None Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Oak Associates Ltd | Institution | 80,000 | No Change | 0 | 0 % | $820,800 | $944,000 | $123,200 | 15.00 % | $0 | | | | | | News Article | History of Oak Associates Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | 846,200 | Added More | 675,500 | 395.72 % | $8,682,012 | $9,985,160 | $1,303,148 | 15.00 % | $1,040,270 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund | No Data | 766,719 | New Holding | 766,719 | 100 % | $7,866,537 | $9,047,284 | $1,180,747 | 15.00 % | $1,180,747 | | | | | | News Article | History of Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 3,273 | Sold Some | -103 | -3.05 % | $33,581 | $38,621 | $5,040 | 15.00 % | $-159 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 1,095 | Added More | 585 | 114.70 % | $11,235 | $12,921 | $1,686 | 15.00 % | $901 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of King Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Pharmaceuticals Ultrasector Profund | Health/Biotech | 1,978 | Added More | 1,518 | 330.00 % | $20,294 | $23,340 | $3,046 | 15.00 % | $2,338 | | | | | | News Article | History of Profunds - Pharmaceuticals Ultrasector Profund Ownership Of King Pharmaceuticals Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Bb And T Corp | Institution | 42,924 | Added More | 26,779 | 165.86 % | $443,405 | $506,503 | $63,098 | 14.23 % | $39,365 | | | | | | News Article | History of Bb And T Corp Ownership Of King Pharmaceuticals Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Natcan Investment Management Inc | Institution | 38,300 | Added More | 21,400 | 126.62 % | $395,639 | $451,940 | $56,301 | 14.23 % | $31,458 | | | | | | News Article | History of Natcan Investment Management Inc Ownership Of King Pharmaceuticals Inc |
| 2009-10-02 | 2009-09-30 | 13F-HR | Bb And T Asset Management Llc | Institution | 450,450 | Added More | 44,400 | 10.93 % | $4,747,743 | $5,315,310 | $567,567 | 11.95 % | $55,944 | | | | | | News Article | History of Bb And T Asset Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Riversource Large Cap Series Inc - Riversource Disciplined Equity Fund | Large-Cap Core | | Sold All | -400,546 | -100 % | | | | 11.95 % | $-504,688 | | | | | | News Article | History of Riversource Large Cap Series Inc - Riversource Disciplined Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Income Stock Fund | Equity Income | 112,200 | Sold Some | -77,200 | -40.76 % | $1,182,588 | $1,323,960 | $141,372 | 11.95 % | $-97,272 | | | | | | News Article | History of Usaa Mutual Funds Trust - Income Stock Fund Ownership Of King Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 34,200 | Sold Some | -31,200 | -47.70 % | $360,468 | $403,560 | $43,092 | 11.95 % | $-39,312 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - Balanced Fund | Mixed-Asset Target Allocation Growth | 42,467 | Sold Some | -81,880 | -65.84 % | $453,548 | $501,111 | $47,563 | 10.48 % | $-91,706 | | | | | | News Article | History of American Century Mutual Funds Inc - Balanced Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - Veedot Fund | Mid-Cap Core | | Sold All | -151,000 | -100 % | | | | 10.48 % | $-169,120 | | | | | | News Article | History of American Century Mutual Funds Inc - Veedot Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Independence Funds Trust - Fusion Fund | No Data | | Sold All | -1,785 | -100 % | | | | 10.48 % | $-1,999 | | | | | | News Article | History of American Independence Funds Trust - Fusion Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 598,863 | No Change | 0 | 0 % | $6,395,857 | $7,066,583 | $670,727 | 10.48 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 239,100 | No Change | 0 | 0 % | $2,553,588 | $2,821,380 | $267,792 | 10.48 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | | Sold All | -2,200 | -100 % | | | | 10.48 % | $-2,464 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va International Value Portfolio | Multi-Cap Value | 16,600 | No Change | 0 | 0 % | $177,288 | $195,880 | $18,592 | 10.48 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va International Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Trust Co - Global Large Company Series | Large-Cap Core | 92,576 | Added More | 439 | 0.47 % | $988,712 | $1,092,397 | $103,685 | 10.48 % | $492 | | | | | | News Article | History of Dfa Investment Trust Co - Global Large Company Series Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Trust Co - International Value Series | Multi-Cap Value | 1,641,530 | No Change | 0 | 0 % | $17,531,540 | $19,370,054 | $1,838,514 | 10.48 % | $0 | | | | | | News Article | History of Dfa Investment Trust Co - International Value Series Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Eclipse Funds - Mainstay Balanced Fund | Mixed-Asset Target Allocation Growth | 60,793 | New Holding | 60,793 | 100 % | $649,269 | $717,357 | $68,088 | 10.48 % | $68,088 | | | | | | News Article | History of Eclipse Funds - Mainstay Balanced Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Eclipse Funds Inc - Mainstay 13030 Core Fund | No Data | 46,123 | New Holding | 46,123 | 100 % | $492,594 | $544,251 | $51,658 | 10.48 % | $51,658 | | | | | | News Article | History of Eclipse Funds Inc - Mainstay 13030 Core Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Eclipse Funds Inc - Mainstay S And P 500 Index Fund | S&P 500 Index | 30,036 | New Holding | 30,036 | 100 % | $320,784 | $354,425 | $33,640 | 10.48 % | $33,640 | | | | | | News Article | History of Eclipse Funds Inc - Mainstay S And P 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series I - Value Fund | Multi-Cap Value | 22,900 | New Holding | 22,900 | 100 % | $244,572 | $270,220 | $25,648 | 10.48 % | $25,648 | | | | | | News Article | History of Fidelity Advisor Series I - Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series Viii - Value Leaders Fund | Multi-Cap Core | 7,900 | New Holding | 7,900 | 100 % | $84,372 | $93,220 | $8,848 | 10.48 % | $8,848 | | | | | | News Article | History of Fidelity Advisor Series Viii - Value Leaders Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Beacon Street Trust - Fidelity Tax Managed Stock Fund | Specialty & Misc | 313,400 | New Holding | 313,400 | 100 % | $3,347,112 | $3,698,120 | $351,008 | 10.48 % | $351,008 | | | | | | News Article | History of Fidelity Beacon Street Trust - Fidelity Tax Managed Stock Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Capital Trust - Fidelity Disciplined Equity Fund | Specialty & Misc | 4,700,000 | New Holding | 4,700,000 | 100 % | $50,196,000 | $55,460,000 | $5,264,000 | 10.48 % | $5,264,000 | | | | | | News Article | History of Fidelity Capital Trust - Fidelity Disciplined Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Spartan 500 Index Fund | S&P 500 Index | | Sold All | -343,602 | -100 % | | | | 10.48 % | $-384,834 | | | | | | News Article | History of Fidelity Commonwealth Trust - Spartan 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Equity Index Fund | S&P 500 Index | 24,897 | New Holding | 24,897 | 100 % | $265,900 | $293,785 | $27,885 | 10.48 % | $27,885 | | | | | | News Article | History of First American Investment Funds Inc - Equity Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Large Cap Value Fund | Large-Cap Value | 3,371 | New Holding | 3,371 | 100 % | $36,002 | $39,778 | $3,776 | 10.48 % | $3,776 | | | | | | News Article | History of First American Investment Funds Inc - Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Quantitative Large Cap Core Fund | Large-Cap Core | 6,444 | New Holding | 6,444 | 100 % | $68,822 | $76,039 | $7,217 | 10.48 % | $7,217 | | | | | | News Article | History of First American Investment Funds Inc - Quantitative Large Cap Core Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Goldman Sachs Trust - Goldman Sachs Structured Large Cap Growth Fund | Large-Cap Growth | | Sold All | -222,650 | -100 % | | | | 10.48 % | $-249,368 | | | | | | News Article | History of Goldman Sachs Trust - Goldman Sachs Structured Large Cap Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Goldman Sachs Trust - Goldman Sachs Structured Large Cap Value Fund | Large-Cap Value | | Sold All | -329,465 | -100 % | | | | 10.48 % | $-369,001 | | | | | | News Article | History of Goldman Sachs Trust - Goldman Sachs Structured Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Global Health Fund | Health/Biotech | 229 | New Holding | 229 | 100 % | $2,446 | $2,702 | $256 | 10.48 % | $256 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Global Health Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Kld 400 Social Index Fund | Specialty & Misc | | Sold All | -3,894 | -100 % | | | | 10.48 % | $-4,361 | | | | | | News Article | History of Ishares Trust - Ishares Kld 400 Social Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Core Index Fund | Mid-Cap Core | | Sold All | -28,977 | -100 % | | | | 10.48 % | $-32,454 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Core Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Value Index Fund | Mid-Cap Value | 30,148 | New Holding | 30,148 | 100 % | $321,981 | $355,746 | $33,766 | 10.48 % | $33,766 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSR | Janus Investment Fund - Intech Risk-Managed Value Fund | No Data | 16,300 | No Compare | | | $174,084 | $192,340 | $18,256 | 10.48 % | | | | | | | News Article | History of Janus Investment Fund - Intech Risk-Managed Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | | Sold All | -41,300 | -100 % | | | | 10.48 % | $-46,256 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Common Stock Fund | Large-Cap Core | 66,037 | Sold Some | -8,250 | -11.10 % | $705,275 | $779,237 | $73,961 | 10.48 % | $-9,240 | | | | | | News Article | History of Mainstay Funds - Mainstay Common Stock Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Equity Index Fund | Specialty & Misc | 6,212 | Sold Some | -344 | -5.24 % | $66,344 | $73,302 | $6,957 | 10.48 % | $-385 | | | | | | News Article | History of Mainstay Funds - Mainstay Equity Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Oak Associates Funds - Live Oak Health Sciences Fund | Health/Biotech | 42,000 | No Change | 0 | 0 % | $448,560 | $495,600 | $47,040 | 10.48 % | $0 | | | | | | News Article | History of Oak Associates Funds - Live Oak Health Sciences Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Putnam Investment Funds - Putnam Capital Opportunities Fund | Small-Cap Core | 311,183 | Sold Some | -26,500 | -7.84 % | $3,323,434 | $3,671,959 | $348,525 | 10.48 % | $-29,680 | | | | | | News Article | History of Putnam Investment Funds - Putnam Capital Opportunities Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | 457,007 | Added More | 45,400 | 11.02 % | $4,880,835 | $5,392,683 | $511,848 | 10.48 % | $50,848 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Schroder Global Series Trust - North American Equity Fund | Specialty & Misc | | Sold All | -45,187 | -100 % | | | | 10.48 % | $-50,609 | | | | | | News Article | History of Schroder Global Series Trust - North American Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Global Fund Series Inc - Global Smaller Companies Fund | Global Small/Mid-Cap Core | 40,000 | New Holding | 40,000 | 100 % | $427,200 | $472,000 | $44,800 | 10.48 % | $44,800 | | | | | | News Article | History of Seligman Global Fund Series Inc - Global Smaller Companies Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 1,611,900 | Added More | 1,437,130 | 822.29 % | $17,215,092 | $19,020,420 | $1,805,328 | 10.48 % | $1,609,586 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard International Equity Index Funds - Vanguard Total World Stock Index Fund | No Data | 2,331 | No Change | 0 | 0 % | $24,895 | $27,506 | $2,611 | 10.48 % | $0 | | | | | | News Article | History of Vanguard International Equity Index Funds - Vanguard Total World Stock Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Advisors Inner Circle Fund - Cambiar Conquistador Fund | Small-Cap Core | 87,000 | New Holding | 87,000 | 100 % | $928,290 | $1,026,600 | $98,310 | 10.59 % | $98,310 | | | | | | News Article | History of Advisors Inner Circle Fund - Cambiar Conquistador Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Hancock John Equity Trust - Small Cap Fund | Small-Cap Core | 86,500 | Sold Some | -91,500 | -51.40 % | $922,955 | $1,020,700 | $97,745 | 10.59 % | $-103,395 | | | | | | News Article | History of Hancock John Equity Trust - Small Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Mid Cap Value Fund | Mid-Cap Value | 50,000 | No Change | 0 | 0 % | $533,500 | $590,000 | $56,500 | 10.59 % | $0 | | | | | | News Article | History of Harbor Funds - Harbor Mid Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Balanced Fund | Mixed-Asset Target Allocation Growth | 6,800 | Added More | 2,200 | 47.82 % | $72,556 | $80,240 | $7,684 | 10.59 % | $2,486 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Balanced Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Enhanced Index Core Equity Fund | Large-Cap Core | 1,500 | Added More | 500 | 50.00 % | $16,005 | $17,700 | $1,695 | 10.59 % | $565 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Enhanced Index Core Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Enhanced Index Value Fund | Multi-Cap Value | 19,920 | No Change | 0 | 0 % | $212,546 | $235,056 | $22,510 | 10.59 % | $0 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Enhanced Index Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Fund | Small-Cap Core | | Sold All | -15,500 | -100 % | | | | 10.59 % | $-17,515 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | 7,932 | New Holding | 7,932 | 100 % | $84,634 | $93,598 | $8,963 | 10.59 % | $8,963 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | 16,158 | New Holding | 16,158 | 100 % | $172,406 | $190,664 | $18,259 | 10.59 % | $18,259 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 8,370 | New Holding | 8,370 | 100 % | $89,308 | $98,766 | $9,458 | 10.59 % | $9,458 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio | Specialty & Misc | 12,592 | New Holding | 12,592 | 100 % | $134,357 | $148,586 | $14,229 | 10.59 % | $14,229 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio | Health/Biotech | | Sold All | -98,384 | -100 % | | | | 10.59 % | $-111,174 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Fundamental Us Large Company Index Fund | Large-Cap Core | 16,900 | No Change | 0 | 0 % | $180,323 | $199,420 | $19,097 | 10.59 % | $0 | | | | | | News Article | History of Schwab Capital Trust - Schwab Fundamental Us Large Company Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | 800,000 | Sold Some | -600,000 | -42.85 % | $8,536,000 | $9,440,000 | $904,000 | 10.59 % | $-678,000 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Premier Equity Fund | Specialty & Misc | 450,000 | No Change | 0 | 0 % | $4,801,500 | $5,310,000 | $508,500 | 10.59 % | $0 | | | | | | News Article | History of Schwab Capital Trust - Schwab Premier Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | 267,725 | New Holding | 267,725 | 100 % | $2,856,626 | $3,159,155 | $302,529 | 10.59 % | $302,529 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Tocqueville Trust - The Tocqueville Fund | Specialty & Misc | 38,200 | New Holding | 38,200 | 100 % | $407,594 | $450,760 | $43,166 | 10.59 % | $43,166 | | | | | | News Article | History of Tocqueville Trust - The Tocqueville Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Windsor Funds - Vanguard Windsor Ii Fund | Large-Cap Value | | Sold All | -123,100 | -100 % | | | | 10.59 % | $-139,103 | | | | | | News Article | History of Vanguard Windsor Funds - Vanguard Windsor Ii Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Victory Portfolios - Victory Stock Index Fund | S&P 500 Index | 934 | Sold Some | -27 | -2.80 % | $9,966 | $11,021 | $1,055 | 10.59 % | $-31 | | | | | | News Article | History of Victory Portfolios - Victory Stock Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-28 | 2009-06-30 | 13F-HR/A | Bridgewater Investment Management Llc | Institution | | Sold All | -1,771 | -100 % | | | | 10.59 % | $-2,001 | | | | | | News Article | History of Bridgewater Investment Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Advisors Inner Circle Fund - Lsv Conservative Core Equity Fund | Multi-Cap Value | 5,800 | Sold Some | -2,500 | -30.12 % | $60,610 | $68,440 | $7,830 | 12.91 % | $-3,375 | | | | | | News Article | History of Advisors Inner Circle Fund - Lsv Conservative Core Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Tax Managed Multi Cap Opportunity Portfolio - Tax Managed Multi Cap Opportunity Portfolio | Specialty & Misc | 125,000 | New Holding | 125,000 | 100 % | $1,306,250 | $1,475,000 | $168,750 | 12.91 % | $168,750 | | | | | | News Article | History of Tax Managed Multi Cap Opportunity Portfolio - Tax Managed Multi Cap Opportunity Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Unified Series Trust - Marathon Value Portfolio | Multi-Cap Value | | Sold All | -57,930 | -100 % | | | | 12.91 % | $-78,206 | | | | | | News Article | History of Unified Series Trust - Marathon Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 10,072 | Added More | 2,687 | 36.38 % | $105,252 | $118,850 | $13,597 | 12.91 % | $3,627 | | | | | | News Article | History of Kbc Group Nv Ownership Of King Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Dreyfus Index Funds Inc - Dreyfus S And P 500 Index Fund | S&P 500 Index | 60,626 | No Change | 0 | 0 % | $631,117 | $715,387 | $84,270 | 13.35 % | $0 | | | | | | News Article | History of Dreyfus Index Funds Inc - Dreyfus S And P 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide Large Cap Value Fund | Large-Cap Value | | Sold All | -9,906 | -100 % | | | | 13.35 % | $-13,769 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 315,278 | Sold Some | -221,004 | -41.21 % | $3,282,044 | $3,720,280 | $438,236 | 13.35 % | $-307,196 | | | | | | News Article | History of Credit Agricole S A Ownership Of King Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 24,610 | New Holding | 24,610 | 100 % | $263,573 | $290,398 | $26,825 | 10.17 % | $26,825 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfuslaurel Funds Inc - Midcap Stock Fund | Mid-Cap Core | 244,490 | New Holding | 244,490 | 100 % | $2,618,488 | $2,884,982 | $266,494 | 10.17 % | $266,494 | | | | | | News Article | History of Dreyfuslaurel Funds Inc - Midcap Stock Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfuslaurel Funds Inc - Tax Managed Growth Fund | Large-Cap Core | 22,702 | New Holding | 22,702 | 100 % | $243,138 | $267,884 | $24,745 | 10.17 % | $24,745 | | | | | | News Article | History of Dreyfuslaurel Funds Inc - Tax Managed Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 678,855 | New Holding | 678,855 | 100 % | $7,433,462 | $8,010,489 | $577,027 | 7.76 % | $577,027 | | | | | | News Article | History of Eaton Vance Management Ownership Of King Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 679,377 | New Holding | 679,377 | 100 % | $7,439,178 | $8,016,649 | $577,470 | 7.76 % | $577,470 | | | | | | News Article | History of Eaton Vance Management Ownership Of King Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Health Care Etf | Health/Biotech | 500 | Sold Some | -360 | -41.86 % | $5,305 | $5,900 | $595 | 11.21 % | $-428 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Health Care Etf Ownership Of King Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - S And P Equal Weight Etf | Specialty & Misc | 382,551 | Added More | 292,175 | 323.28 % | $4,058,866 | $4,514,102 | $455,236 | 11.21 % | $347,688 | | | | | | News Article | History of Rydex Etf Trust - S And P Equal Weight Etf Ownership Of King Pharmaceuticals Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 178,707 | Sold Some | -500,444 | -73.68 % | $1,897,868 | $2,108,743 | $210,874 | 11.11 % | $-590,524 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of King Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 9,361,237 | Sold Some | -3,649,411 | -28.04 % | $99,509,949 | $110,462,597 | $10,952,647 | 11.00 % | $-4,269,811 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl S And P 500 Index Fund | S&P 500 Index | 11,340 | Added More | 3,124 | 38.02 % | $119,297 | $133,812 | $14,515 | 12.16 % | $3,999 | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl S And P 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Barclays Global Investors Funds - Bond Index Fund | Specialty & Misc | 51,510 | No Change | 0 | 0 % | $541,885 | $607,818 | $65,933 | 12.16 % | $0 | | | | | | News Article | History of Barclays Global Investors Funds - Bond Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Calvert Variable Series Inc - Ameritas Mid Cap Growth Portfolio | Mid-Cap Growth | | Sold All | -11,714 | -100 % | | | | 12.16 % | $-14,994 | | | | | | News Article | History of Calvert Variable Series Inc - Ameritas Mid Cap Growth Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Master Investment Portfolio - Active Stock Portfolio | Specialty & Misc | | Sold All | -114,363 | -100 % | | | | 12.16 % | $-146,385 | | | | | | News Article | History of Master Investment Portfolio - Active Stock Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Master Investment Portfolio - S And P 500 Index Master Portfolio | S&P 500 Index | 51,510 | No Change | 0 | 0 % | $541,885 | $607,818 | $65,933 | 12.16 % | $0 | | | | | | News Article | History of Master Investment Portfolio - S And P 500 Index Master Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Morgan Stanley Equally Weighted S And P 500 Fund - None | Specialty & Misc | | Sold All | -187,987 | -100 % | | | | 12.16 % | $-240,623 | | | | | | News Article | History of Morgan Stanley Equally Weighted S And P 500 Fund - None Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Morgan Stanley Select Dimensions Investment Series - Utilities Portfolio | Utility | 18,209 | Sold Some | -370 | -1.99 % | $191,559 | $214,866 | $23,308 | 12.16 % | $-474 | | | | | | News Article | History of Morgan Stanley Select Dimensions Investment Series - Utilities Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Morgan Stanley Variable Investment Series - Information Portfolio | Specialty & Misc | 3,480 | No Change | 0 | 0 % | $36,610 | $41,064 | $4,454 | 12.16 % | $0 | | | | | | News Article | History of Morgan Stanley Variable Investment Series - Information Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund | No Data | 350 | Added More | 60 | 20.68 % | $3,682 | $4,130 | $448 | 12.16 % | $77 | | | | | | News Article | History of Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Revenueshares Etf Trust - Revenueshares Large Cap Fund | Large-Cap Core | 937 | Added More | 182 | 24.10 % | $9,857 | $11,057 | $1,199 | 12.16 % | $233 | | | | | | News Article | History of Revenueshares Etf Trust - Revenueshares Large Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 4,170 | Added More | 299 | 7.72 % | $43,868 | $49,206 | $5,338 | 12.16 % | $383 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 340 | Added More | 60 | 21.42 % | $3,577 | $4,012 | $435 | 12.16 % | $77 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Nova Fund | Specialty & Misc | 880 | Added More | 220 | 33.33 % | $9,258 | $10,384 | $1,126 | 12.16 % | $282 | | | | | | News Article | History of Rydex Variable Trust - Nova Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Summit Mutual Funds Inc - Balanced Index Portfolio | Flexible Portfolio | 304 | No Change | 0 | 0 % | $3,198 | $3,587 | $389 | 12.16 % | $0 | | | | | | News Article | History of Summit Mutual Funds Inc - Balanced Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Summit Mutual Funds Inc - Zenith Portfolio | Specialty & Misc | 6,413 | Sold Some | -251 | -3.76 % | $67,465 | $75,673 | $8,209 | 12.16 % | $-321 | | | | | | News Article | History of Summit Mutual Funds Inc - Zenith Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Wegener Investment Trust - Wegener Investment Trust | Specialty & Misc | 1,400 | New Holding | 1,400 | 100 % | $14,728 | $16,520 | $1,792 | 12.16 % | $1,792 | | | | | | News Article | History of Wegener Investment Trust - Wegener Investment Trust Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Mid Cap Value Equity Trust | Mid-Cap Value | 72,439 | New Holding | 72,439 | 100 % | $742,500 | $854,780 | $112,280 | 15.12 % | $112,280 | | | | | | News Article | History of John Hancock Trust - Mid Cap Value Equity Trust Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advisors Series Trust - Al Frank Fund | Specialty & Misc | 40,000 | No Change | 0 | 0 % | $410,000 | $472,000 | $62,000 | 15.12 % | $0 | | | | | | News Article | History of Advisors Series Trust - Al Frank Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | 158,400 | Added More | 61,700 | 63.80 % | $1,623,600 | $1,869,120 | $245,520 | 15.12 % | $95,635 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 655,663 | Added More | 355,724 | 118.59 % | $6,720,546 | $7,736,823 | $1,016,278 | 15.12 % | $551,372 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 100,970 | New Holding | 100,970 | 100 % | $1,034,943 | $1,191,446 | $156,504 | 15.12 % | $156,504 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqequity 500 Index Portfolio | S&P 500 Index | 71,010 | Added More | 1,100 | 1.57 % | $727,853 | $837,918 | $110,066 | 15.12 % | $1,705 | | | | | | News Article | History of Eq Advisors Trust - Eqequity 500 Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | 4,300 | New Holding | 4,300 | 100 % | $44,075 | $50,740 | $6,665 | 15.12 % | $6,665 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqmutual Shares Portfolio | Specialty & Misc | 9,000 | New Holding | 9,000 | 100 % | $92,250 | $106,200 | $13,950 | 15.12 % | $13,950 | | | | | | News Article | History of Eq Advisors Trust - Eqmutual Shares Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqtcw Equity Portfolio | Specialty & Misc | 20,982 | New Holding | 20,982 | 100 % | $215,066 | $247,588 | $32,522 | 15.12 % | $32,522 | | | | | | News Article | History of Eq Advisors Trust - Eqtcw Equity Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Guidestone Funds - Capital Opportunities | Multi-Cap Core | | Sold All | -117,700 | -100 % | | | | 15.12 % | $-182,435 | | | | | | News Article | History of Guidestone Funds - Capital Opportunities Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc - Hartford Global Health Hls Fund | Health/Biotech | 114 | New Holding | 114 | 100 % | $1,169 | $1,345 | $177 | 15.12 % | $177 | | | | | | News Article | History of Hartford Series Fund Inc - Hartford Global Health Hls Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Homestead Funds Inc - Stock Index Fund | Specialty & Misc | | Sold All | -51,510 | -100 % | | | | 15.12 % | $-79,841 | | | | | | News Article | History of Homestead Funds Inc - Stock Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Homestead Funds Inc - Value Fund | Multi-Cap Value | 51,510 | No Change | 0 | 0 % | $527,978 | $607,818 | $79,841 | 15.12 % | $0 | | | | | | News Article | History of Homestead Funds Inc - Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Indexed Equity Fund | S&P 500 Index | 44,448 | Added More | 1,000 | 2.30 % | $455,592 | $524,486 | $68,894 | 15.12 % | $1,550 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Indexed Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Value Equity Fund | Multi-Cap Value | 26,310 | New Holding | 26,310 | 100 % | $269,678 | $310,458 | $40,781 | 15.12 % | $40,781 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Value Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Mma Praxis Mutual Funds - Mma Praxis Value Index Fund | Large-Cap Value | 7,944 | No Change | 0 | 0 % | $81,426 | $93,739 | $12,313 | 15.12 % | $0 | | | | | | News Article | History of Mma Praxis Mutual Funds - Mma Praxis Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 3,376 | Sold Some | -881 | -20.69 % | $34,604 | $39,837 | $5,233 | 15.12 % | $-1,366 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Bull | Specialty & Misc | 4,830 | Added More | 2,852 | 144.18 % | $49,508 | $56,994 | $7,487 | 15.12 % | $4,421 | | | | | | News Article | History of Profunds - Profund Vp Bull Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 7,560 | Added More | 3,090 | 69.12 % | $77,490 | $89,208 | $11,718 | 15.12 % | $4,790 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Pharmaceuticals | Specialty & Misc | 10,764 | New Holding | 10,764 | 100 % | $110,331 | $127,015 | $16,684 | 15.12 % | $16,684 | | | | | | News Article | History of Profunds - Profund Vp Pharmaceuticals Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Ultrabull | Specialty & Misc | 1,012 | Added More | 644 | 175.00 % | $10,373 | $11,942 | $1,569 | 15.12 % | $998 | | | | | | News Article | History of Profunds - Profund Vp Ultrabull Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund | Mid-Cap Core | 61,500 | New Holding | 61,500 | 100 % | $630,375 | $725,700 | $95,325 | 15.12 % | $95,325 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Goldman Sachs Mid Cap Value Fund | No Data | | Sold All | -59,913 | -100 % | | | | 15.12 % | $-92,865 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Goldman Sachs Mid Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 13,921 | Added More | 13,090 | 1575.21 % | $142,690 | $164,268 | $21,578 | 15.12 % | $20,290 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 1,914,333 | New Holding | 1,914,333 | 100 % | $19,621,913 | $22,589,129 | $2,967,216 | 15.12 % | $2,967,216 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Balanced Portfolio | Flexible Portfolio | 89,095 | Added More | 3,050 | 3.54 % | $913,224 | $1,051,321 | $138,097 | 15.12 % | $4,728 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Balanced Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Equity Index Portfolio | Specialty & Misc | 48,603 | No Change | 0 | 0 % | $498,181 | $573,515 | $75,335 | 15.12 % | $0 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Equity Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vantagepoint Funds - Vantagepoint Discovery Fund | No Data | 73,500 | New Holding | 73,500 | 100 % | $753,375 | $867,300 | $113,925 | 15.12 % | $113,925 | | | | | | News Article | History of Vantagepoint Funds - Vantagepoint Discovery Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advantus Series Fund Inc - Index 500 Portfolio | No Data | | Sold All | -10,901 | -100 % | | | | 15.00 % | $-16,788 | | | | | | News Article | History of Advantus Series Fund Inc - Index 500 Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | American Century Quantitative Equity Funds Inc - Utilities Fund | Utility | | Sold All | -62,339 | -100 % | | | | 15.00 % | $-96,002 | | | | | | News Article | History of American Century Quantitative Equity Funds Inc - Utilities Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Flex Funds - The Quantex Fund | Multi-Cap Core | 5,455 | New Holding | 5,455 | 100 % | $55,968 | $64,369 | $8,401 | 15.00 % | $8,401 | | | | | | News Article | History of Flex Funds - The Quantex Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Gartmore Variable Insurance Trust - Nvit Multi-Manager Large Cap Value Fund | No Data | 125,100 | New Holding | 125,100 | 100 % | $1,283,526 | $1,476,180 | $192,654 | 15.00 % | $192,654 | | | | | | News Article | History of Gartmore Variable Insurance Trust - Nvit Multi-Manager Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Gartmore Variable Insurance Trust - Nvit Multi-Manager Mid Cap Value Fund | No Data | 109,775 | New Holding | 109,775 | 100 % | $1,126,292 | $1,295,345 | $169,054 | 15.00 % | $169,054 | | | | | | News Article | History of Gartmore Variable Insurance Trust - Nvit Multi-Manager Mid Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Goldman Sachs Trust - Goldman Sachs Structured International Equity Fund | Gold Oriented | | Sold All | -118,027 | -100 % | | | | 15.00 % | $-181,762 | | | | | | News Article | History of Goldman Sachs Trust - Goldman Sachs Structured International Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 24 | Sold Some | -1 | -4.00 % | $246 | $283 | $37 | 15.00 % | $-2 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio | Specialty & Misc | | Sold All | -94,916 | -100 % | | | | 15.00 % | $-146,171 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio | Mid-Cap Core | | Sold All | -113,163 | -100 % | | | | 15.00 % | $-174,271 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Value Portfolio | Multi-Cap Value | | Sold All | -24,219 | -100 % | | | | 15.00 % | $-37,297 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Emerging Growth Fund | Emerging Markets | 6,244 | Sold Some | -28,260 | -81.90 % | $64,063 | $73,679 | $9,616 | 15.00 % | $-43,520 | | | | | | News Article | History of Mml Series Investment Fund - Mml Emerging Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Equity Index | Specialty & Misc | 7,567 | No Change | 0 | 0 % | $77,637 | $89,291 | $11,653 | 15.00 % | $0 | | | | | | News Article | History of Mml Series Investment Fund - Mml Equity Index Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Blend Fund | Specialty & Misc | 34,000 | Sold Some | -12,700 | -27.19 % | $348,840 | $401,200 | $52,360 | 15.00 % | $-19,558 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Blend Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Enhanced Index Core Equity Fund | Multi-Cap Core | 1,500 | Sold Some | -800 | -34.78 % | $15,390 | $17,700 | $2,310 | 15.00 % | $-1,232 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Enhanced Index Core Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 12,929 | Added More | 12,477 | 2760.39 % | $132,652 | $152,562 | $19,911 | 15.00 % | $19,215 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | New Covenant Funds - New Covenant Growth Fund | No Data | | Sold All | -1,700 | -100 % | | | | 15.00 % | $-2,618 | | | | | | News Article | History of New Covenant Funds - New Covenant Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pacific Select Fund | Pacific Region | 100,600 | Sold Some | -37,200 | -26.99 % | $1,032,156 | $1,187,080 | $154,924 | 15.00 % | $-57,288 | | | | | | News Article | History of Pacific Select Fund - Pacific Select Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Value Index Portfolio | No Data | 741 | No Compare | | | $7,603 | $8,744 | $1,141 | 15.00 % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Value Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -308,374 | -100 % | | | | 15.00 % | $-474,896 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Dws Equity 500 Index Portfolio - Dws Equity 500 Index Portfolio | S&P 500 Index | 61,575 | Sold Some | -2,300 | -3.60 % | $632,991 | $726,585 | $93,594 | 14.78 % | $-3,496 | | | | | | News Article | History of Dws Equity 500 Index Portfolio - Dws Equity 500 Index Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Dws Institutional Funds - Dws Equity 500 Index Fund | S&P 500 Index | 61,575 | Sold Some | -2,300 | -3.60 % | $632,991 | $726,585 | $93,594 | 14.78 % | $-3,496 | | | | | | News Article | History of Dws Institutional Funds - Dws Equity 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | 13F-HR/A | Hollencrest Securities Llc | Institution | | Sold All | -15,000 | -100 % | | | | 14.78 % | $-22,800 | | | | | | News Article | History of Hollencrest Securities Llc Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Legg Mason Partners Equity Trust - Legg Mason Partners S And P 500 Index Fund | S&P 500 Index | 7,516 | New Holding | 7,516 | 100 % | $77,264 | $88,689 | $11,424 | 14.78 % | $11,424 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners S And P 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Batterymarch Growth And Income Portfolio | Multi-Cap Growth | | Sold All | -160,800 | -100 % | | | | 14.78 % | $-244,416 | | | | | | News Article | History of Met Investors Series Trust - Batterymarch Growth And Income Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio | Multi-Cap Growth | | Sold All | -173,700 | -100 % | | | | 14.78 % | $-264,024 | | | | | | News Article | History of Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Riversource Variable Series Trust - Riversource Variable Portfolio Core Bond Fund | No Data | 21,289 | Sold Some | -17,665 | -45.34 % | $218,851 | $251,210 | $32,359 | 14.78 % | $-26,851 | | | | | | News Article | History of Riversource Variable Series Trust - Riversource Variable Portfolio Core Bond Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | | Sold All | -259,238 | -100 % | | | | 14.78 % | $-394,042 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 483,435 | Sold Some | -675,189 | -58.27 % | $4,955,209 | $5,704,533 | $749,324 | 15.12 % | $-1,046,543 | | | | | | News Article | History of Amvescap Plc Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fidelity International Ltd | Institution | 2,819,820 | New Holding | 2,819,820 | 100 % | $28,903,155 | $33,273,876 | $4,370,721 | 15.12 % | $4,370,721 | | | | | | News Article | History of Fidelity International Ltd Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 24,881,179 | Added More | 24,153,346 | 3318.52 % | $255,032,085 | $293,597,912 | $38,565,827 | 15.12 % | $37,437,686 | | | | | | News Article | History of Fmr Corp Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Munder Series Trust - Munder Index 500 Fund | S&P 500 Index | | Sold All | -9,339 | -100 % | | | | 15.12 % | $-14,475 | | | | | | News Article | History of Munder Series Trust - Munder Index 500 Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Pax World Balanced Fund - Pax World Growth Fund | Multi-Cap Growth | 60,000 | New Holding | 60,000 | 100 % | $615,000 | $708,000 | $93,000 | 15.12 % | $93,000 | | | | | | News Article | History of Pax World Balanced Fund - Pax World Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Rs Variable Products Trust - Rs Partners Vip Series | Specialty & Misc | 4,764 | New Holding | 4,764 | 100 % | $48,831 | $56,215 | $7,384 | 15.12 % | $7,384 | | | | | | News Article | History of Rs Variable Products Trust - Rs Partners Vip Series Ownership Of King Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Nova Fund | Large-Cap Core | 1,490 | Sold Some | -50 | -3.24 % | $15,273 | $17,582 | $2,310 | 15.12 % | $-78 | | | | | | News Article | History of Rydex Series Funds - Nova Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q/A | Assetmark Funds - Assetmark Large Cap Value Fund | Multi-Cap Value | 29,410 | New Holding | 29,410 | 100 % | $305,276 | $347,038 | $41,762 | 13.68 % | $41,762 | | | | | | News Article | History of Assetmark Funds - Assetmark Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Bb And T Funds - Equity Index Fund | S&P 500 Index | 51,510 | No Change | 0 | 0 % | $534,674 | $607,818 | $73,144 | 13.68 % | $0 | | | | | | News Article | History of Bb And T Funds - Equity Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Dryden Index Series Fund - Dryden Stock Index Fund | Specialty & Misc | 20,533 | New Holding | 20,533 | 100 % | $213,133 | $242,289 | $29,157 | 13.68 % | $29,157 | | | | | | News Article | History of Dryden Index Series Fund - Dryden Stock Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | 626,100 | New Holding | 626,100 | 100 % | $6,498,918 | $7,387,980 | $889,062 | 13.68 % | $889,062 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Destiny Portfolios - Capital Development Fund | Specialty & Misc | 1,200,000 | No Change | 0 | 0 % | $12,456,000 | $14,160,000 | $1,704,000 | 13.68 % | $0 | | | | | | News Article | History of Fidelity Destiny Portfolios - Capital Development Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -11,150 | -100 % | | | | 13.68 % | $-15,833 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund | Large-Cap Core | 24,400 | Sold Some | -185,400 | -88.36 % | $253,272 | $287,920 | $34,648 | 13.68 % | $-263,268 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Growth Fund | Large-Cap Growth | | Sold All | -127,400 | -100 % | | | | 13.68 % | $-180,908 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Growth Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Value Fund | Large-Cap Value | 373,700 | Sold Some | -209,200 | -35.88 % | $3,879,006 | $4,409,660 | $530,654 | 13.68 % | $-297,064 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q/A | Select Sector Spdr Trust - Health Care Select Sector Spdr Fund | Health/Biotech | | Sold All | -563,130 | -100 % | | | | 13.68 % | $-799,645 | | | | | | News Article | History of Select Sector Spdr Trust - Health Care Select Sector Spdr Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Bond Fund | Specialty & Misc | 24,779 | New Holding | 24,779 | 100 % | $257,206 | $292,392 | $35,186 | 13.68 % | $35,186 | | | | | | News Article | History of Tiaa Cref Life Fund - Bond Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Growth Equity Fund | Large-Cap Growth | 32,906 | New Holding | 32,906 | 100 % | $341,564 | $388,291 | $46,727 | 13.68 % | $46,727 | | | | | | News Article | History of Tiaa Cref Life Fund - Growth Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 2,997 | Added More | 185 | 6.57 % | $31,109 | $35,365 | $4,256 | 13.68 % | $263 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 65,400 | New Holding | 65,400 | 100 % | $678,852 | $771,720 | $92,868 | 13.68 % | $92,868 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Diefa Fund | Specialty & Misc | 5,038 | Added More | 3,591 | 248.16 % | $52,294 | $59,448 | $7,154 | 13.68 % | $5,099 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Diefa Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Midcap Earnings Fund | Mid-Cap Core | 5,051 | No Change | 0 | 0 % | $52,429 | $59,602 | $7,172 | 13.68 % | $0 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Midcap Earnings Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Total Earnings Fund | Specialty & Misc | 652 | Added More | 51 | 8.48 % | $6,768 | $7,694 | $926 | 13.68 % | $72 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Total Earnings Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Axp Investment Series Inc - Riversource Disciplined Large Cap Value Fund | No Data | 75,743 | New Holding | 75,743 | 100 % | $788,485 | $893,767 | $105,283 | 13.35 % | $105,283 | | | | | | News Article | History of Axp Investment Series Inc - Riversource Disciplined Large Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Bb And T Funds - Mid Cap Value Fund | Mid-Cap Value | 405,950 | Added More | 70,800 | 21.12 % | $4,225,940 | $4,790,210 | $564,271 | 13.35 % | $98,412 | | | | | | News Article | History of Bb And T Funds - Mid Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia International Fund Variable Series | Global Flex Port | 670 | Sold Some | -35 | -4.96 % | $6,975 | $7,906 | $931 | 13.35 % | $-49 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia International Fund Variable Series Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Eaton Vance Series Trust - Eaton Vance Tax Managed Growth Fund 1 0 | Multi-Cap Growth | | Sold All | -152,305 | -100 % | | | | 13.35 % | $-211,704 | | | | | | News Article | History of Eaton Vance Series Trust - Eaton Vance Tax Managed Growth Fund 1 0 Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 121,911 | Sold Some | -989 | -0.80 % | $1,269,094 | $1,438,550 | $169,456 | 13.35 % | $-1,375 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Value Index Fund | Multi-Cap Value | 393,869 | Sold Some | -29,557 | -6.98 % | $4,100,176 | $4,647,654 | $547,478 | 13.35 % | $-41,084 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 69,241 | Added More | 4,020 | 6.16 % | $720,799 | $817,044 | $96,245 | 13.35 % | $5,588 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | 16,547 | Sold Some | -17 | -0.10 % | $172,254 | $195,255 | $23,000 | 13.35 % | $-24 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 373,080 | Sold Some | -29,960 | -7.43 % | $3,883,763 | $4,402,344 | $518,581 | 13.35 % | $-41,644 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Value Index Fund | Mid-Cap Value | 422,164 | Sold Some | -17,926 | -4.07 % | $4,394,727 | $4,981,535 | $586,808 | 13.35 % | $-24,917 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pacific Life Funds - Pl Comstock Fund | Specialty & Misc | | Sold All | -8,980 | -100 % | | | | 13.35 % | $-12,482 | | | | | | News Article | History of Pacific Life Funds - Pl Comstock Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pacific Life Funds - Pl Main Street Core Fund | Multi-Cap Core | 8,680 | New Holding | 8,680 | 100 % | $90,359 | $102,424 | $12,065 | 13.35 % | $12,065 | | | | | | News Article | History of Pacific Life Funds - Pl Main Street Core Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Putnam Variable Trust - Putnam Vt Capital Opportunities Fund | Specialty & Misc | | Sold All | -27,943 | -100 % | | | | 13.35 % | $-38,841 | | | | | | News Article | History of Putnam Variable Trust - Putnam Vt Capital Opportunities Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Riversource Investment Series Inc - Riversource Mid Cap Value Fund | Mid-Cap Value | 1,127,885 | Added More | 83,464 | 7.99 % | $11,741,283 | $13,309,043 | $1,567,760 | 13.35 % | $116,015 | | | | | | News Article | History of Riversource Investment Series Inc - Riversource Mid Cap Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Riversource Strategic Allocation Series Inc - Riversource Strategic Allocation Fund | Flexible Portfolio | 93,211 | New Holding | 93,211 | 100 % | $970,327 | $1,099,890 | $129,563 | 13.35 % | $129,563 | | | | | | News Article | History of Riversource Strategic Allocation Series Inc - Riversource Strategic Allocation Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Large Cap Composite Portfolio | Large-Cap Core | 216 | New Holding | 216 | 100 % | $2,249 | $2,549 | $300 | 13.35 % | $300 | | | | | | News Article | History of Seasons Series Trust - Large Cap Composite Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Large Cap Growth Portfolio | Large-Cap Growth | 1,746 | New Holding | 1,746 | 100 % | $18,176 | $20,603 | $2,427 | 13.35 % | $2,427 | | | | | | News Article | History of Seasons Series Trust - Large Cap Growth Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Large Cap Value Portfolio | Large-Cap Value | 3,076 | New Holding | 3,076 | 100 % | $32,021 | $36,297 | $4,276 | 13.35 % | $4,276 | | | | | | News Article | History of Seasons Series Trust - Large Cap Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Value Portfolio | Mid-Cap Value | 7,387 | New Holding | 7,387 | 100 % | $76,899 | $87,167 | $10,268 | 13.35 % | $10,268 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 2,229 | New Holding | 2,229 | 100 % | $23,204 | $26,302 | $3,098 | 13.35 % | $3,098 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Tax Managed Growth Portfolio - Tax Managed Growth Portfolio | Multi-Cap Growth | | Sold All | -152,305 | -100 % | | | | 13.35 % | $-211,704 | | | | | | News Article | History of Tax Managed Growth Portfolio - Tax Managed Growth Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Vanguard Montgomery Funds - Vanguard Market Neutral Fund | Specialty & Misc | | Sold All | -4,900 | -100 % | | | | 13.35 % | $-6,811 | | | | | | News Article | History of Vanguard Montgomery Funds - Vanguard Market Neutral Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Variable Insurance Products Iii - Balanced Portfolio | Flexible Portfolio | 25,100 | New Holding | 25,100 | 100 % | $261,291 | $296,180 | $34,889 | 13.35 % | $34,889 | | | | | | News Article | History of Variable Insurance Products Iii - Balanced Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 1,423,533 | Added More | 587,116 | 70.19 % | $14,818,979 | $16,797,689 | $1,978,711 | 13.35 % | $816,091 | | | | | | News Article | History of Wells Fargo And Co Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Global Equity Fund | Global Flex Port | | Sold All | -2,036,070 | -100 % | | | | 13.35 % | $-2,830,137 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Global Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | | Sold All | -1,912,600 | -100 % | | | | 13.35 % | $-2,658,514 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Malvern Funds - Vanguard Asset Allocation Fund | Flexible Portfolio | 168,833 | Sold Some | -34,188 | -16.83 % | $1,757,552 | $1,992,229 | $234,678 | 13.35 % | $-47,521 | | | | | | News Article | History of Vanguard Malvern Funds - Vanguard Asset Allocation Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Malvern Funds - Vanguard Asset Allocation Fund | Flexible Portfolio | 203,021 | No Change | 0 | 0 % | $2,113,449 | $2,395,648 | $282,199 | 13.35 % | $0 | | | | | | News Article | History of Vanguard Malvern Funds - Vanguard Asset Allocation Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Malvern Funds - Vanguard Capital Value Fund | Multi-Cap Value | | Sold All | -192,530 | -100 % | | | | 13.35 % | $-267,617 | | | | | | News Article | History of Vanguard Malvern Funds - Vanguard Capital Value Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Blackrock Large Cap Series Funds Inc - Blackrock Large Cap Core Plus Fund | No Data | | Sold All | -200 | -100 % | | | | 11.84 % | $-250 | | | | | | News Article | History of Blackrock Large Cap Series Funds Inc - Blackrock Large Cap Core Plus Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Fidelity Trend Fund - Fidelity Trend Fund | Large-Cap Core | 221,600 | New Holding | 221,600 | 100 % | $2,337,880 | $2,614,880 | $277,000 | 11.84 % | $277,000 | | | | | | News Article | History of Fidelity Trend Fund - Fidelity Trend Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Balanced Portfolio | Mixed-Asset Target Allocation Growth | 2,700 | New Holding | 2,700 | 100 % | $28,485 | $31,860 | $3,375 | 11.84 % | $3,375 | | | | | | News Article | History of Janus Aspen Series - Balanced Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Growth And Income Portfolio | Multi-Cap Growth | | Sold All | -6,300 | -100 % | | | | 11.84 % | $-7,875 | | | | | | News Article | History of Janus Aspen Series - Growth And Income Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Asset Allocation Fund | Flexible Portfolio | 598,540 | Added More | 357,934 | 148.76 % | $6,314,597 | $7,062,772 | $748,175 | 11.84 % | $447,418 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Asset Allocation Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Core Investment Fund | Flexible Portfolio | 236,273 | Added More | 2,960 | 1.26 % | $2,492,680 | $2,788,021 | $295,341 | 11.84 % | $3,700 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Core Investment Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Select Industries Fund | Specialty Dvsfd Eq | 14,174 | Added More | 570 | 4.18 % | $149,536 | $167,253 | $17,718 | 11.84 % | $713 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Select Industries Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Mgi Funds - Mgi Us Large Cap Growth Equity Fund | Large-Cap Growth | 14,600 | New Holding | 14,600 | 100 % | $154,030 | $172,280 | $18,250 | 11.84 % | $18,250 | | | | | | News Article | History of Mgi Funds - Mgi Us Large Cap Growth Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Mgi Funds - Mgi Us Large Cap Value Equity Fund | Large-Cap Value | 19,000 | New Holding | 19,000 | 100 % | $200,450 | $224,200 | $23,750 | 11.84 % | $23,750 | | | | | | News Article | History of Mgi Funds - Mgi Us Large Cap Value Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Old Mutual Advisor Funds Ii - Old Mutual Focused Fund | Large-Cap Core | 222,200 | No Change | 0 | 0 % | $2,344,210 | $2,621,960 | $277,750 | 11.84 % | $0 | | | | | | News Article | History of Old Mutual Advisor Funds Ii - Old Mutual Focused Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Bond Fund | Specialty & Misc | 471,034 | New Holding | 471,034 | 100 % | $4,969,409 | $5,558,201 | $588,793 | 11.84 % | $588,793 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Bond Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Value Index Fund | No Data | 85,748 | Added More | 7,905 | 10.15 % | $904,641 | $1,011,826 | $107,185 | 11.84 % | $9,881 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 52,724 | Sold Some | -46,888 | -47.07 % | $556,238 | $622,143 | $65,905 | 11.84 % | $-58,610 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | 998,300 | New Holding | 998,300 | 100 % | $10,532,065 | $11,779,940 | $1,247,875 | 11.84 % | $1,247,875 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | 2,377,803 | Sold Some | -183,696 | -7.17 % | $25,085,822 | $28,058,075 | $2,972,254 | 11.84 % | $-229,620 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 2,289,436 | New Holding | 2,289,436 | 100 % | $24,153,550 | $27,015,345 | $2,861,795 | 11.84 % | $2,861,795 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 794,079 | Added More | 264,294 | 49.88 % | $8,377,533 | $9,370,132 | $992,599 | 11.84 % | $330,368 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 95,139 | No Change | 0 | 0 % | $1,003,716 | $1,122,640 | $118,924 | 11.84 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 116,639 | Added More | 21,500 | 22.59 % | $1,230,541 | $1,376,340 | $145,799 | 11.84 % | $26,875 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | | Sold All | -250,000 | -100 % | | | | 13.35 % | $-347,500 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of King Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Ge Institutional Funds - Income Fund | Equity Income | 966 | New Holding | 966 | 100 % | $10,056 | $11,399 | $1,343 | 13.35 % | $1,343 | | | | | | News Article | History of Ge Institutional Funds - Income Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Funds Group Trust - Touchstone Mid Cap Fund | Mid-Cap Core | 258,510 | Added More | 82,090 | 46.53 % | $2,691,089 | $3,050,418 | $359,329 | 13.35 % | $114,105 | | | | | | News Article | History of Touchstone Funds Group Trust - Touchstone Mid Cap Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | 47,500 | Added More | 34,500 | 265.38 % | $495,900 | $560,500 | $64,600 | 13.02 % | $46,920 | | | | | | News Article | History of Jefferies Group Inc Ownership Of King Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Laudus Trust - Laudus Rosenberg International Discovery Fund | Global Flex Port | | Sold All | -222,338 | -100 % | | | | 13.02 % | $-302,380 | | | | | | News Article | History of Laudus Trust - Laudus Rosenberg International Discovery Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Midcap Value Portfolio | No Data | | Sold All | -79,688 | -100 % | | | | 13.02 % | $-108,376 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Midcap Value Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR/A | Bank Of Oklahoma National Association | No Data | 18,120 | No Compare | | | $187,904 | $213,816 | $25,912 | 13.78 % | | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of King Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company Large Cap Core Fund | Large-Cap Core | 16,270 | New Holding | 16,270 | 100 % | $168,720 | $191,986 | $23,266 | 13.78 % | $23,266 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company Large Cap Core Fund Ownership Of King Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 194,649 | New Holding | 194,649 | 100 % | $2,018,510 | $2,296,858 | $278,348 | 13.78 % | $278,348 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of King Pharmaceuticals Inc |
RSS feed for KG